Next Article in Journal
Molecular Epidemiology and Phylogeography of Domestically Established Bacillus anthracis Isolates Collected in the United States from 1982 to 2013
Previous Article in Journal
Whole-Genome Sequence of Plant Pathogenic Pectobacterium brasiliense Strain 25ASUB12 Isolated from Summer Squash (Cucurbita pepo L.) in Mississippi
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

Future Prospects for Omics Sciences: Expanding the Boundaries of Systems Biology

Laboratory of Botany, Biotechnology and Plant Protection, Faculty of Science, Ibn Tofail University, Kenitra BP 242, Morocco
J. Genome Biotechnol. Genet. 2026, 1(2), 8; https://doi.org/10.3390/jgbg1020008
Submission received: 18 March 2026 / Revised: 16 April 2026 / Accepted: 3 June 2026 / Published: 23 June 2026

Abstract

High-throughput omics technologies have profoundly transformed our approach to studying biological systems, enabling system-level exploration of genomes, transcriptomes, proteomes, metabolomes, and beyond. Despite these advances, current omics approaches remain limited in capturing dynamic temporal changes, preserving spatial organization within tissues, and effectively integrating multi-layered datasets into coherent biological interpretations. The aim of this review is to provide a structured and critical overview of established, emerging, and conceptual omics sciences, and to propose a unifying framework that expands the boundaries of systems biology. This review organizes established and emerging omics into a structured framework, highlighting conceptual innovations such as adaptomics, resiliomics, chrono-adaptomics, and signalomics. We discuss technological advances, computational strategies, and potential applications for research and clinical practice.

1. Introduction

Omics sciences refer to a collection of high-throughput disciplines that aim to comprehensively characterize classes of biological molecules within a system. These include genomics (DNA), transcriptomics (RNA), proteomics (proteins), and metabolomics (metabolites), among others. Collectively, omics approaches enable system-level investigation of biological processes by capturing global molecular profiles rather than focusing on individual components.
Over the past two decades, omics technologies have transformed the life sciences by enabling comprehensive, systems-level characterization of biological molecules and processes. Historically rooted in genomics, high-throughput sequencing first allowed researchers to decode entire genomes, laying the foundation for subsequent global analyses of transcripts, proteins, and metabolites [1,2]. This progression from analyses focusing on individual molecular layers (e.g., genomics or transcriptomics alone) to integrated multi-omics approaches represents a paradigm shift in biological research, facilitating unprecedented insights into cellular heterogeneity, tissue architecture, and organismal complexity [2,3]. High-throughput omics now encompasses a wide range of molecular layers including genomics, transcriptomics, proteomics, metabolomics, and emerging spatial and single-cell modalities, each contributing uniquely to our understanding of living systems [2,4].
Fundamental omics fields such as genomics, transcriptomics, proteomics, and metabolomics have been extensively applied across diverse disciplines—from plant-pathogen interactions to human disease [2]. For example, omics technologies have elucidated molecular mechanisms underlying plant immunity by profiling genomic, transcriptomic, proteomic, and metabolomic changes in response to pathogenic attack [2,5]. In biomedical contexts, transcriptomic and proteomic profiling has been crucial in unraveling the cellular heterogeneity of complex disorders such as osteoarthritis, where integration of multi-omics data has identified novel biomarkers and pathways [6,7,8,9]. For example, genomics has been widely applied in genome-wide association studies (GWAS) to identify disease-associated variants, transcriptomics has enabled the characterization of gene expression changes in cancer and developmental biology, and proteomics has been used to identify biomarkers and signaling pathways in complex diseases such as Alzheimer’s disease and cancer.
Advances in single-cell omics and spatial multi-omics have further refined our capacity to dissect biological systems with high resolution. Single-cell technologies enable the characterization of individual cellular states and rare populations, revealing heterogeneity that bulk analyses obscure [10]. Spatial omics maintains the positional context of molecular profiles within tissues, linking molecular signatures with architectural features and enhancing our understanding of cellular interactions within microenvironments [11]. Together, these innovations move omics research beyond static snapshots toward dynamic, context-aware views of complex living systems.
Despite these significant advancements, fundamental challenges remain. Integration of multi-omics datasets demands sophisticated computational tools and analytical strategies to manage heterogeneity in scale, dimensionality, and data modality. Narrative reviews highlight that while statistical approaches and machine learning techniques have enabled progress in data integration, issues such as missing values, dimensionality, and data quality complicate interpretation and cross-layer synthesis [12]. As a result, the next frontier of omics science will be defined not only by novel experimental technologies but also by frameworks that contextualize temporal dynamics, environmental responses, and regulatory complexity across biological scales [13,14].
In this review, we provide a structured and critical overview of both established omics disciplines and emerging conceptual omics layers. In this context, an ‘omics layer’ refers to a distinct level of biological information (e.g., genome, transcriptome, proteome, metabolome) that can be measured independently and integrated to provide a systems-level understanding. We organize these fields into thematic chapters—including regulatory, environmental, system-specific, and integrative omics—and evaluate their current status, limitations, and future prospects. We also explore increasingly speculative domains poised to extend the limits of systems biology, emphasizing how technological innovation and conceptual expansion together shape the future of omics sciences.
In addition to established omics disciplines, this review also introduces a series of emerging and conceptual omics layers that aim to extend the current boundaries of systems biology. These conceptual omics are proposed as theoretical frameworks rather than fully established experimental disciplines, reflecting both the rapid evolution of technologies and the need for new integrative paradigms.
This review adopts a cross-disciplinary systems biology perspective, using examples from plant, microbial, and biomedical systems to illustrate generalizable principles of omics integration. The proposed emerging and conceptual omics frameworks are not intended as fully independent experimental disciplines, but rather as integrative conceptual layers that extend existing multi-omics approaches.

2. Conceptual vs. Experimental Omics: Scope and Classification

To ensure conceptual clarity, it is important to distinguish between different levels of maturity within omics sciences. Established omics disciplines, such as genomics, transcriptomics, proteomics, and metabolomics, are supported by robust experimental methodologies and standardized analytical frameworks [15]. In contrast, emerging omics fields—including single-cell omics, spatial omics, and fluxomics—are rapidly evolving with ongoing technological advancements but still face limitations in scalability and integration [16].
Beyond these domains, this review introduces a series of conceptual omics, such as adaptomics, resiliomics, and signalomics, which aim to describe higher-order biological processes, including adaptation, robustness, and cellular decision-making. These conceptual omics are proposed as theoretical frameworks rather than fully established experimental disciplines, reflecting current technological limitations and the need for integrative models in systems biology. Finally, more speculative omics domains, such as vibratomics or consciencomics, are discussed as long-term perspectives that may guide future scientific exploration.
Figure 1 summarizes the hierarchical organization and evolution of omics sciences from fundamental to integrative layers. This figure illustrates the hierarchical organization of omics sciences, from established molecular layers (genomics, transcriptomics, proteomics, metabolomics) to emerging and conceptual frameworks. Each layer represents a distinct level of biological information, while arrows indicate integration pathways across layers. The figure highlights how multi-omics approaches combine these levels to enable systems-level understanding of biological processes.
To avoid conceptual fragmentation, we categorize omics into four levels:
(i)
Established omics (experimentally mature),
(ii)
Emerging omics (technologically advancing),
(iii)
Conceptual omics (frameworks describing system-level processes), and
(iv)
Speculative omics (long-term perspectives).
Importantly, conceptual omics are not proposed as independent experimental layers, but as integrative abstractions that organize multi-omics data into biologically meaningful dimensions such as adaptation, resilience, and signaling.

3. Fundamental Omics (Core of Life Sciences)

The foundation of modern systems biology is built on a series of large-scale molecular profiling techniques collectively referred to as fundamental omics. These approaches aim to comprehensively catalog and quantify macromolecules—ranging from DNA to small metabolites—providing an essential framework for understanding organismal complexity. These fundamental omics layers serve as the basis upon which more specialized and integrative omics methods are developed [17,18].

3.1. Genomics

Genomics entails the systematic analysis of complete DNA sequences of organisms, capturing genetic information at the level of entire genomes [19,20]. The initial breakthrough in this field came with the sequencing of the human genome, which established a reference blueprint for human genetic variation [21]. Contemporary genomic studies extend this paradigm to diverse species, including agriculturally important plants and non-model organisms, elucidating both conserved and unique genomic features.
By identifying genetic variants such as single nucleotide polymorphisms (SNPs), copy number variations, and structural rearrangements, genomics enables researchers to link genotype with phenotype and disease susceptibility [22]. In plant sciences, comparative genomics has shed light on genomic diversity underlying stress tolerance and adaptation. For example, recent work demonstrates how integrative genomic analysis can reveal complex trait architectures in crops, highlighting genome-wide variation associated with valuable agronomic characteristics [23,24,25,26]. Such studies underscore the centrality of genomics in both basic and applied biological research [27,28,29,30,31,32].

3.2. Transcriptomics

While genomics provides the static blueprint of potential biological function, transcriptomics captures the dynamic expression of genes across time, tissues, and conditions by quantifying RNA molecules [33,34,35]. Transcriptomic profiling includes bulk RNA sequencing (RNA-seq), which measures average gene expression across populations of cells, and single-cell RNA-seq, which resolves gene expression at the resolution of individual cells. More recently, spatial transcriptomics technologies have emerged, preserving the spatial context of RNA expression within tissue architecture [36,37]. For instance, technologies such as 10× Genomics Visium and MERFISH enable spatially resolved gene expression profiling, allowing researchers to map transcriptional activity within tissue architecture. These approaches have been applied in tumor microenvironment studies and brain tissue organization.
Transcriptomics is widely used to map tissue heterogeneity, characterize disease microenvironments, and identify regulatory networks driving biological processes. For example, spatial mapping of transcripts in tumor tissues has advanced our understanding of cellular interactions in immuno-oncology, providing insight into microenvironmental influences on therapy response [38,39,40,41,42]. Emerging spatial methods further link transcript expression to histological features, enabling a more integrated view of tissue biology [42,43,44,45].

3.3. Proteomics

Whereas transcriptomics reflects the potential for protein synthesis, proteomics directly measures the expressed protein complement of a cell or tissue, including post-translational modifications (PTMs) that regulate protein activity, localization, and interactions. Mass spectrometry (MS) has become the cornerstone of quantitative proteomics, offering high-throughput identification and quantification of thousands of proteins in complex biological samples [46,47,48,49,50].
Proteomic profiling facilitates functional annotation of genomes, identification of protein complexes, and discovery of biomarkers associated with physiological states and diseases. The development of advanced MS platforms with increased sensitivity and dynamic range has expanded proteomic depth, allowing detection of low-abundance proteins and diverse PTMs. Proteomics thus provides a critical functional layer, linking gene expression to biochemical activity [15,48].

3.4. Metabolomics

Completing the fundamental omics suite, metabolomics focuses on the comprehensive profiling of small molecules (metabolites) that represent the end products of cellular processes (Table 1). Because metabolites are directly tied to biochemical reactions and cellular physiology, metabolomic signatures provide a functional readout of metabolic activity and phenotypic state [51,52,53,54].
Metabolomics employs technologies such as liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectroscopy to capture the diversity of metabolites within biological samples. These profiles can reveal disruptions in metabolic pathways associated with disease, stress responses, or environmental adaptation. Unlike genomic and transcriptomic measures, which reflect potential biological activity, metabolomics reflects realized biochemical function, making it a powerful tool for phenotype characterization and biomarker discovery [54,55,56].
This table summarizes major omics categories, their measurable biological features, associated technologies, and representative applications. The ‘Examples’ column provides real-world use cases illustrating how each omics approach has been applied in research and clinical contexts.

4. Functional and Structural Omics

While fundamental omics describe static inventories of molecules, functional and structural omics (Figure 2) aim to characterize how biomolecules interact, change conformation, and carry out coordinated functions within complex systems [18,54,57]. These layers provide insights into dynamic regulatory networks, post-translational modifications, and emergent properties that cannot be deduced from sequence alone. These approaches leverage advancements in interactomics, quantitative mass spectrometry, high-resolution structural biology, and emerging real-time imaging techniques to bridge genotype and phenotype at a mechanistic level [58,59].
This figure illustrates the integration of multiple omics layers into a unified systems biology framework. Each layer represents a distinct biological dimension, while connecting arrows indicate interactions and data integration pathways. The figure emphasizes the transition from single-omics analysis to multi-omics and integrative modeling.

4.1. Interactomics

Interactomics encompasses the systematic mapping of molecular interactions, including protein–protein, protein–DNA, and protein–RNA networks. High-throughput affinity purification coupled to mass spectrometry (AP-MS), yeast two-hybrid screens, and cross-linking methods now enable large-scale reconstruction of interactomes, revealing how biomolecules assemble into functional complexes [60,61]. The unbiased characterization of interaction networks has shed light on cellular signaling crosstalk, the modular organization of pathways, and the rewiring of networks in disease states [62,63].
For example, integrated protein–protein and protein–RNA interactome maps have recently been used to dissect signaling networks involved in immune cell activation and differentiation, illustrating how perturbations in interactomes can underlie pathological phenotypes [64,65,66]. These network maps are increasingly used in systems biology modeling to predict functional dependencies and regulatory bottlenecks [64,65,66].

4.2. Phosphoproteomics & Glycomics

Post-translational modifications (PTMs) add an essential layer of functional regulation that cannot be inferred from genomic or transcriptomic data alone. Phosphoproteomics quantitatively profiles phosphorylation events across thousands of sites, enabling characterization of kinase activity and signaling cascades. Recent advancements in high-resolution mass spectrometry have improved phosphoproteome coverage, allowing temporal profiling of dynamic signaling responses, such as stress adaptation and drug responses in cancer cells [67,68,69].
In parallel, glycomics addresses the complex landscape of glycosylation patterns on proteins and lipids. Glycosylation modulates protein folding, stability, and cell–cell interactions, and its dysregulation is implicated in cancer progression, immunity, and developmental disorders. Recent analytical platforms combining liquid chromatography, lectin arrays, and advanced mass spectrometry have expanded glycan structural resolution, facilitating mapping of glycosylation signatures associated with disease [70,71,72].

4.3. Lipidomics

Lipidomics provides comprehensive characterization of lipid species, which play essential roles in membrane architecture, energy storage, and signaling. The lipidome comprises thousands of structurally diverse molecules, including glycerophospholipids, sphingolipids, sterols, and fatty acids. Advances in shotgun lipidomics and ion mobility mass spectrometry enable high-throughput quantification of lipid classes across tissues and conditions [73,74,75].
Recent lipidomic studies have revealed condition-specific lipid remodeling in metabolic diseases and during cellular stress responses, underscoring the role of lipids not only as structural components but also as bioactive mediators of inflammation and metabolic regulation [76,77,78].

4.4. Structural Omics

Structural omics extends traditional functional layers by examining the three-dimensional conformation and physical dynamics of biomolecules, thereby linking structure with function (Table 2).

4.4.1. Conformomics

Conformomic refers to the systematic characterization of dynamic conformational states of proteins and nucleic acids. Unlike traditional structural biology focused on static snapshots (e.g., X-ray crystallography), conformomics exploits techniques such as cryo-electron microscopy (cryo-EM), nuclear magnetic resonance (NMR), and hydrogen–deuterium exchange mass spectrometry (HDX-MS) to capture ensembles of conformations [79,80,81,82,83]. Recent computational tools like AlphaFold2 not only predict static structures with high accuracy but also facilitate exploration of conformational landscapes and folding intermediates, enabling deeper functional interpretation of proteomes [79,80,81,82,83].

4.4.2. Vibratomics (Speculative)

Vibratomic is a speculative conceptual model that seeks to characterize biologically relevant molecular vibrations at the quantum–biological interface. Emerging spectroscopic technologies (e.g., two-dimensional infrared spectroscopy) allow probing of vibrational modes associated with protein function and solvation dynamics. While still far from routine omics application, the idea of integrating vibrational signatures into systems biology could one day provide insight into energetics and conformational flexibility at a level beyond standard structural analyses [84,85].

4.4.3. Electromomics (Speculative)

Electromomic represents another forward-looking concept focused on intracellular electromagnetic fields as potential regulators of molecular communication. Living cells maintain ion gradients and electrical potentials that influence processes such as membrane transport and signal transduction. Although direct high-throughput measurement of intracellular electric fields remains technologically challenging, advances in nanoscale sensors and voltage-sensitive probes may one day enable profiling of bioelectrical states as an integrated molecular layer [86,87].
Both vibratomic and electromomic remain speculative, but they underscore a growing interest in expanding omics beyond chemical inventories to include physical and biophysical dimensions of living systems.
Selected References for Functional and Structural Omics:
  • Interactomics:
    Comprehensive interactome mapping in immune systems highlights functional network reorganization [62].
    Protein–RNA interaction networks reveal signaling dependencies [88,89].
  • Phosphoproteomics/Glycomics:
    Advances in phosphoproteomics reveal signaling dynamics in drug response [90,91,92].
    Glycan structural profiling and disease associations [93,94].
  • Lipidomics:
    Lipid remodeling in metabolic stress and disease [77].
    High-throughput lipidomics and analytical innovation [95].
  • Structural Omics:
    Cryo-EM and AlphaFold2 expand conformational landscape analysis [80].

5. Regulatory and Control Omics

Unlike classical omics that quantify molecular abundance, the following regulatory omics frameworks focus on dynamic system properties such as signaling, adaptation, and stability. These layers are derived from time-resolved and multi-omics datasets, rather than representing independent measurement technologies.
Regulatory and control omics encompass molecular layers that govern the dynamic regulation (Figure 3, Table 3), signaling processes, adaptive decision-making, and robustness of biological systems. Beyond static descriptions of molecular abundance, these omics aim to capture mechanisms by which cells interpret internal and external cues, modulate gene expression programs, and maintain functional integrity in response to perturbations [96,97]. Recent advances in high-resolution imaging, longitudinal sampling, and computational modeling enable the emergence of novel frameworks that expand the boundaries of traditional regulatory biology [98,99].

5.1. Epigenomics

Epigenomics refers to the genome-wide profiling of heritable and dynamic regulatory modifications that impact gene expression without altering nucleotide sequence. Key epigenomic marks include DNA methylation, histone post-translational modifications (e.g., acetylation, methylation), and chromatin accessibility [100,101]. These layers collectively shape the regulatory landscape by determining how DNA is packaged and accessed by transcriptional machinery. Techniques such as bisulfite sequencing and ATAC-seq have enabled precise quantification of these features, revealing their pivotal roles in development, cellular differentiation, and disease pathogenesis [102,103]. Integrative epigenomic analyses have been especially impactful in cancer research, where aberrant methylation and chromatin states drive oncogenic programs [104,105].

5.2. Signalomics (Emerging)

Signalomics is an emerging conceptual omics layer that seeks to systematically characterize the dynamic signaling processes within cells. Unlike conventional omics focused on molecular abundance, signalomics encompasses the temporal patterns of intracellular signals mediated by second messengers such as Ca2+, cAMP, diacylglycerol, and kinase cascade activation. With the advent of live-cell imaging, fluorescent biosensors, and high-throughput kinetic assays, it is now feasible to quantify signaling dynamics at high temporal resolution [106,107,108]. These data provide insights into how cells interpret gradients, stressors, and developmental cues. Because cellular decision-making is intimately tied to signaling dynamics, signalomics represents a critical frontier in understanding regulatory networks [109,110].

5.3. Decisiomics

Decisiomics focuses on the molecular and network processes that underlie cellular decision-making, such as lineage commitment, apoptosis, quiescence, and cell cycle transitions. Rather than cataloging expression levels, decisomics investigates functional thresholds, bistability, and attractor states that govern phenotypic switches [111,112]. For example, the interplay between transcription factors and feedback loops can determine whether a hematopoietic progenitor differentiates along one lineage or another. Systems biology approaches integrating transcriptomic, proteomic, and dynamic modeling data are essential to capture these decision landscapes, and decisomics formalizes this regulatory dimension [113,114,115].

5.4. Adaptomics

Adaptomics is proposed as a new omics framework for systematically characterizing molecular adaptation trajectories in response to dynamic environmental stress. Traditional omics often capture static states at single time points, limiting insights into adaptation processes that unfold over time [13]. Adaptomics addresses this by integrating longitudinal multi-omics profiles (transcriptomics, proteomics, metabolomics) collected across multiple perturbation phases. This approach allows the quantification of trajectory features, such as the speed and direction of molecular response, decoupling transient stress responses from sustained adaptive changes.
  • What it measures:
Adaptomics quantifies molecular trajectories: changes in gene expression, protein abundance, and metabolite levels as a function of environmental challenges (e.g., temperature shifts, nutrient limitations, pathogen attack). Such data can distinguish immediate stress responses from later adaptive states.
  • Experimental approaches:
Adaptomic studies require controlled perturbations with multi-timepoint sampling, coupled with longitudinal multi-omics data acquisition. Computational modeling—such as trajectory inference, dynamic network reconstruction, and time-series clustering—is essential to extract adaptive features.
  • Scientific value:
Adaptomics differentiates response vs. adaptation, offering insights into resilience, plasticity, and evolutionary strategies. It has broad relevance across plants (abiotic and biotic stress), microbial ecology (adaptation to changing environments), and disease (adaptive drug resistance).
We propose the concept of adaptomics as a system-level framework to characterize dynamic molecular trajectories underlying biological adaptation to environmental constraints.
Adaptomics builds on concepts from temporal multi-omics and dynamic systems biology to provide a temporal dimension often missing in conventional studies [116].

5.5. Resiliomics

Résiliomic expands regulatory omics by focusing on the ability of biological systems to absorb disturbances and return to functional equilibrium—a property often referred to as resilience. While traditional stress-response studies emphasize peak responses, resiliomics quantifies recovery kinetics, amplitude of perturbation effects, and network stability over time.
  • What it measures:
Key metrics include time to baseline recovery, magnitude of deviation from homeostasis, and robustness of interaction networks under stress.
  • Data sources:
Time-series transcriptomics, proteomics, and targeted metabolomics provide the core datasets. Network analysis and stability metrics (e.g., eigenvalues of interaction matrices) help assess resilience.
  • Applications:
Resiliomics has implications for understanding tolerance mechanisms in plants (e.g., drought recovery), human health (recovery after inflammation or therapy), and ecological robustness.
Resiliomics provides a quantitative framework to assess biological robustness beyond classical stress-response analyses.
Conceptually, resiliomics synthesizes stress physiology and systems biology, offering quantitative resilience metrics previously explored in ecology and engineering disciplines [117].

5.6. Chrono-Adaptomics

Chrono-adaptomics bridges chronobiology and adaptomics by examining how temporal rhythms (e.g., circadian, ultradian, seasonal cycles) influence adaptive molecular responses. Circadian clocks orchestrate gene expression and metabolic fluxes, modulating a cell’s capacity to perceive and react to environmental stressors. By combining timeline-based omics (e.g., sampling at defined circadian phases) with adaptive trajectories, chrono-adaptomics reveals how temporal gating impacts adaptive efficiency and outcome.
  • What it measures:
Circadian clock outputs, phase-specific gene networks, time-dependent response amplitudes, and temporal plasticity metrics.
This emerging framework leverages developments in time-resolved omics and rhythmic biology to understand how biological clocks shape adaptation and resilience [118,119].

5.7. Plasticomics

Plasticomic refers to the global analysis of molecular plasticity—the capacity of a system to modify its state in response to repeated perturbations. While adaptomics focuses on single adaptation trajectories, plasticomics examines changes in responsiveness across repeated stimuli (e.g., priming, cellular memory). This includes comparing primary responses (first exposure) with secondary responses (subsequent exposures), revealing mechanisms of acclimation and molecular memory.
  • Importance:
Plasticity underpins learning, immune training, stress tolerance, and developmental flexibility—domains where plasticomic profiling can yield mechanistic insights [120,121].

5.8. Stochastomics

Stochastomics addresses the random variability in gene expression and molecular processes, often framed as biological noise. Even genetically identical cells in identical environments can exhibit heterogeneous expression due to stochastic transcriptional bursting, variable promoter states, and noisy signaling pathways [122,123]. Quantifying this variability at scale—via single-cell transcriptomics and proteomics—provides insight into how noise influences phenotype, fate decisions, and population dynamics [124].
Regulatory and control omics extend beyond static molecular measurements to interrogate how biological systems respond, adapt, decide, and maintain stability under internal and external perturbations. Emerging frameworks such as signalomics, adaptomics, resiliomics, chrono-adaptomics, and plasticomics exemplify future directions poised to deepen our mechanistic understanding of regulatory dynamics.

5.9. Integration of Regulatory Omics into Multi-Omics Frameworks

The integration of regulatory omics into systems biology relies on combining longitudinal multi-omics datasets with computational modeling. Rather than generating independent datasets, frameworks such as adaptomics and resiliomics are derived from existing omics layers (transcriptomics, proteomics, metabolomics) through temporal and network-based analyses.
Key integration strategies include:
  • Time-series modeling: capturing dynamic trajectories of molecular responses.
  • Network inference: reconstructing regulatory and signaling interactions.
  • Trajectory analysis: identifying adaptive pathways and system transitions.
  • Machine learning approaches: integrating heterogeneous datasets across scales.
These approaches allow regulatory omics to act as higher-order descriptors of biological systems rather than standalone measurement layers.
The implementation of regulatory omics requires substantial computational resources, including high-performance computing, cloud-based infrastructures, and advanced machine learning algorithms. The analysis of longitudinal multi-omics datasets is computationally intensive due to high dimensionality, temporal complexity, and data heterogeneity. Current approaches rely on scalable architectures and optimized algorithms, while future developments will likely depend on artificial intelligence and distributed computing frameworks.

6. Environmental and Ecological Omics

Environmental and ecological omics are included to illustrate that systems biology principles extend beyond individual organisms to organism–environment interactions. These examples serve to demonstrate the scalability of omics frameworks rather than to shift the focus of the review.
The application of omics technologies has catalyzed a paradigm shift in how environmental and ecological processes are studied (Figure 4), enabling researchers to move beyond isolated variables and toward integrated, system-level understandings of organism–environment interactions [125,126,127]. Traditional ecological studies have long recognized the complexity of biotic and abiotic interactions, but multi-omics approaches now allow these relationships to be probed at molecular, cellular, and community scales simultaneously [128,129,130]. Such approaches have proven essential for unraveling the mechanisms by which organisms and ecosystems respond to climate variability, pollution, and human-induced habitat transformations [131,132].
This framework is conceptually aligned with the One Health paradigm, which integrates human, animal, and environmental health into a unified systems perspective.

6.1. Eco-Interactomics

Ecological systems are defined by intricate interactions among organisms, their associated microbiomes, and surrounding environmental matrices such as soil and climate [133]. Omics technologies—including metagenomics, metatranscriptomics, proteomics, and metabolomics—have revolutionized the study of such plant–microbe–soil networks, revealing complex interdependencies that underlie nutrient cycling, stress tolerance, and ecosystem function [33,134]. These tools facilitate simultaneous profiling of multiple biological domains, enabling holistic views of community structure and function across ecological gradients.
For example, multi-omics analyses have illuminated molecular dialogues between crop plants and beneficial microorganisms, linking microbial taxa and plant genes to enhanced nutrient uptake and stress resilience, with direct implications for sustainable agriculture and soil health [33,135]. Similar approaches have been used to dissect the biochemical influence of invasive species on soil microbiomes and ecosystem dynamics, enhancing predictive models of ecological responses to perturbations [136].

6.2. Climatonomics

Climate change represents a dominant driver of environmental stress across ecosystems, affecting organismal physiology, community assembly, and biogeochemical cycles [137]. Omics methods provide powerful means to quantify and interpret these changes at multiple biological levels. Recent research has shown that plant–microbiome interactions—critical for host adaptation under stress—are significantly modulated by climatic factors such as elevated CO2, warming, and drought [138,139,140].
Moreover, omics technologies are increasingly applied to marine and terrestrial organisms to understand molecular adaptations to climate stress [141,142]. These include the identification of climate-tolerant genetic variants, stress-responsive metabolic pathways, and epigenetic modifications that enable phenotypic plasticity under rapid environmental change. Such multi-layered insights are fundamental for forecasting ecological outcomes under future climate scenarios and for designing strategies that enhance resilience in vulnerable species and communities [143,144,145,146].

6.3. Anthropomics

Human activities have dramatically reshaped ecosystems around the globe, with urbanization, industrialization, and agricultural intensification exerting profound impacts on biodiversity, habitat structure, and ecosystem services [147]. Anthropogenic stressors—from air and soil pollution to land-use change—influence organisms at molecular, physiological, and population levels. For example, urban air pollutants such as ozone, nitrogen oxides, and particulate matter trigger complex stress responses in plants that are increasingly being characterized through transcriptomic and metabolomic profiling [148].
Omics-based environmental assessments have also improved our understanding of how contaminants affect microbial community dynamics and the capacity of ecosystems to degrade pollutants through bioremediation processes. These insights not only reveal mechanistic responses to anthropogenic stressors but also inform risk assessment frameworks aimed at safeguarding ecological and human health [125].
At larger scales, anthropogenic land-use changes such as deforestation, urban sprawl, and agricultural expansion contribute to biodiversity loss, ecosystem fragmentation, and altered nutrient cycles, fundamentally altering ecosystem functioning [148]. These complex, multi-factorial impacts underscore the importance of integrative omics frameworks to disentangle organismal responses from broader environmental change and to support sustainable ecosystem management.

7. System-Specific Omics

While foundational and integrative omics approaches have provided broad insights into biological regulation (Table 4), a growing body of research focuses on system-specific omics, targeting particular biological systems or organismal interactions [58,149]. These specialized layers of omics science enable researchers to decode the molecular complexity inherent to specific physiological domains, from neural networks to microbial ecosystems.

7.1. Neuro-Omics

Neuro-omics encompasses the application of high-throughput omics techniques to the nervous system, integrating molecular profiles with structural and functional neural data [150,151,152]. Traditional genomics and transcriptomics have been complemented by proteomic, metabolomic, and spatial omics technologies to map molecular networks associated with brain function and disease. For example, multi-omic integration combined with imaging modalities such as MRI and PET has been used to construct multi-molecular brain maps, revealing molecular signatures that correlate with neurodegenerative processes and highlighting potential therapeutic targets for brain diseases [153]. This integrative approach demonstrates how omics technologies can elucidate complex neural mechanisms that would remain inaccessible via reductionist methodologies [154].

7.2. Immunomics

Immunomics refers to global profiling of the immune system, including the characterization of antibody and T-cell receptor repertoires, signaling networks, and functional responses of immune cells. High-throughput sequencing of adaptive immune receptors (Rep-Seq) has expanded our understanding of B and T cell diversity, enabling detailed mapping of immune repertoire landscapes that reflect host responses to infection, vaccination, and disease [155,156]. Comprehensive immune profiling through multi-omics integration—including transcriptomics, proteomics, and functional assays—provides insights into immune cell differentiation and function, as well as cell-type-specific regulatory networks [157]. These combined analyses are pivotal for advancing precision immunology and therapeutic development.

7.3. Microbiomics and Viromics

Microbiomics and viromics leverage omics technologies to characterize microbial communities and viral populations, respectively, in complex environments such as the gut, soil, and host tissues [158,159]. Microbiomics integrates metagenomics, metatranscriptomics, metaproteomics, and metabolomics to reveal both taxonomic composition and functional potential of microbial ecosystems [160,161,162]. Such integrated meta-omics approaches have been instrumental in linking microbiome dynamics with host phenotypes, metabolic activities, and disease states, often employing machine learning to extract clinically relevant patterns from high-dimensional data [163].
Similarly, viromics combines multi-omics and bioinformatics to study viral diversity, dynamics, and host interactions within ecosystems. In veterinary and infectious disease research, multi-omics strategies have enhanced understanding of viral pathogenesis and host responses, paving the way for novel antiviral interventions [164,165].

7.4. Mycomics

Mycomics applies omics technologies specifically to fungal biology, probing the functional roles and dynamics of fungal communities [166]. Fungi represent a diverse kingdom with key ecological, industrial, and clinical importance [167,168,169]. Omics approaches—spanning genomics, transcriptomics, proteomics, and metabolomics—enable comprehensive characterization of fungal genomes, expression patterns, and metabolite profiles, thereby uncovering mechanisms of enzyme production, environmental adaptation, and symbiotic interactions [33,138,170]. These analyses facilitate both basic fungal biology and biotechnological applications, such as enzyme discovery and bio-product development. Although formal reviews on mycomics are less numerous than for bacterial microbiomes, emerging literature highlights the value of integrating multiple omic layers to unravel fungal complexity and functional contributions [171,172,173,174].
System-specific omics disciplines extend high-throughput molecular profiling into targeted biological domains, offering fine-grained insights that complement broader multi-omics frameworks. By dissecting the molecular infrastructure of neural networks, immune landscapes, microbial communities, and fungal ecosystems, these specialized omics approaches contribute to a deeper understanding of biological specificity and complexity, with translational potential across medicine, ecology, and biotechnology.

8. Advanced Molecular Omics

The following speculative omics are presented as conceptual extensions rather than fully defined disciplines, and their inclusion is intended to illustrate possible future directions rather than immediate research priorities. Recent advances in high-resolution measurement technologies have expanded the frontier of omics beyond population-level analyses, enabling interrogation of biological systems at unprecedented scales of resolution and complexity [6,13]. This section highlights the major developments in advanced molecular omics, spanning from single-cell profiling to speculative information-based frameworks that may guide the next generation of systems biology (Figure 5, Table 5).

8.1. Single-Cell Omics

Single-cell omics has revolutionized our understanding of cellular heterogeneity by enabling genomic, transcriptomic, proteomic, and epigenomic profiling at the level of individual cells [175,176,177]. Traditional bulk assays average signals over heterogeneous cell populations, masking critical variation among individual cells [175,176,177,178]. Single-cell transcriptomics, propelled by droplet-based and plate-based platforms, has unveiled rare cell states, lineage hierarchies, and dynamic cellular responses in development, immunity, and disease [179,180,181,182]. More recently, single-cell multimodal approaches integrate gene expression with chromatin accessibility or protein abundance, providing richer, multi-layered insights into cellular state transitions [183,184]. These technologies have revealed, for example, regulatory programs underlying tumor heterogeneity and immune cell diversification in cancer and infection [183,184].

8.2. Spatial Omics

Spatial omics preserves the physical context of molecular measurements within tissues, maintaining the positional information that is essential for understanding cellular interactions and microenvironments [185]. Techniques such as spatial transcriptomics, imaging mass cytometry, and in situ sequencing enable localized mapping of RNA and protein distribution directly in tissue sections [186]. These advances integrate histological structure with molecular phenotypes, bridging molecular biology and tissue architecture [187]. Spatial omics has been transformative in neuroscience, cancer biology, and developmental biology by revealing how spatial context shapes gene regulation, cell–cell communication, and tissue organization [188].

8.3. Fluxomics

Fluxomics focuses on dynamic metabolic flux analysis—the rates at which metabolites are produced, consumed, and transformed within the cell—rather than static abundance measurements [189]. By using stable isotope tracers detected via mass spectrometry or NMR, fluxomics quantifies metabolic pathway activity, providing functional insight into the kinetic organization of metabolism [190,191]. This layer is important for understanding cellular energy allocation, metabolic adaptations to stress, and rewiring in disease states such as cancer and metabolic disorders. Fluxomics complements metabolomic snapshots by linking metabolite profiles to pathway dynamics and physiological responses [192,193].

8.4. Phenomics

Phenomics encompasses large-scale phenotypic mapping that links genotypes and molecular phenotypes to observable traits at organismal and cellular levels [194]. High-throughput phenotyping platforms measure complex traits including morphology, growth kinetics, physiology, and behavior across genetic populations or environmental conditions [195,196]. In agriculture, phenomics accelerates breeding by connecting genomic variation with drought tolerance, yield, and nutrient use efficiency. In biomedical research, phenomic profiling enables systematic characterization of drug responses, developmental defects, and disease progression [195,196]. The integration of phenomics with other omics layers enriches genotype–phenotype mapping and predictive modeling [197].

8.5. Energomics, Thermomics, Pressiomics and Bioenergetic Omics (Emerging)

At the frontier of speculative omics, energy-centric layers aim to quantify physical and biophysical constraints within cells:
Energomics seeks to characterize cellular energy fluxes and distributions of high-energy molecules (e.g., ATP, proton gradients) across physiological states [198].
Thermomics investigates micro-thermal fluctuations and thermodynamic gradients within cellular compartments, potentially linking metabolic activity with localized heat production [199,200].
Pressiomics contemplates mechanical pressures and forces at microscopic scales, such as membrane tension, intracellular crowding, and mechanotransductive stresses [201].
Bioenergetic omics is an emerging conceptual framework aimed at integrating cellular energy production, distribution, and utilization across biological systems. Unlike traditional metabolomics or fluxomics, which capture metabolic intermediates or pathway dynamics, bioenergetic omics seeks to unify energetic processes—including ATP flux, mitochondrial function, redox balance, and thermodynamic constraints—into a coherent systems-level layer.
This framework has the potential to serve as an integrative axis linking multiple omics layers, as energy availability fundamentally constrains gene expression, protein activity, and metabolic fluxes. Advances in live-cell imaging, biosensors, and computational modeling may enable future quantification of bioenergetic states at high resolution.
Conceptually, bioenergetic omics complements emerging fields such as signalomics by providing a unifying energetic context for molecular decision-making and adaptation.
Although current technologies do not yet provide direct, multiplexed measurement frameworks for these physical parameters across entire cell populations, emerging methods in biophysics and live-cell imaging suggest that future advances may render these dimensions tractable. These speculative omics expand the conceptual space of biological measurement to include energy, heat, and force as dimensions of cellular systems.

8.6. Information-Based Omics

In parallel with molecular profiling, information-centred omics frameworks emphasize the organization, processing, and encoding of biological information beyond linear sequences:
Infomics focuses on the flow and processing of biological information within cellular networks, including signaling cascades, gene regulatory circuits, and feedback loops. This perspective aligns with information theory frameworks applied to transcriptional regulation and cellular decision-making [202].
Codomics extends the concept of biological codes beyond the genetic code to include epigenetic, histone modification, and glycan coding systems that influence molecular interactions and phenotypes [203].
Algorithmiomics proposes the study of intrinsic biological logic and computation—measuring the algorithmic or rule-based structures that govern dynamic processes such as differentiation, homeostasis, and adaptation [204].
While still conceptual, these layers illustrate a growing interest in framing biological systems as information processors, where data flow and code interpretation are central to understanding complexity. Tools from computational biology, network science, and machine learning are instrumental in operationalizing these frameworks.

9. Integrative Omics

Figure 6 Schematic representation of multi-omics integration workflows, illustrating data acquisition, preprocessing, integration strategies, and biological interpretation.
Integration of multi-omics data is typically achieved through:
(i)
network-based approaches linking molecular interactions,
(ii)
statistical models integrating heterogeneous datasets, and
(iii)
machine learning frameworks capable of capturing nonlinear relationships across omics layers.
Increasingly, longitudinal and spatially resolved datasets are incorporated to enable dynamic systems modeling.
Integrative omics encompasses analytical strategies that combine multiple layers of biological data to achieve system-level insights into complex biological mechanisms [205]. Rather than analyzing individual omics layers in isolation, multi-omics integration leverages collectively the information contained in genomic, transcriptomic, proteomic, metabolomic, and other molecular profiles [206]. This holistic approach enables researchers to uncover intricate regulatory networks, characterize disease subtypes with higher resolution, and refine biomarker discovery beyond what single-omics analyses can achieve. Such integration has been particularly transformative in areas like nephrology, where machine learning frameworks applied to multi-omics data can reveal novel molecular signatures with clinical relevance for disease progression and prognosis [207].
A defining challenge of integrative omics lies in the interpretation of high-dimensional and heterogeneous datasets, which often exhibit complex interdependencies across molecular layers. Recent advances in artificial intelligence (AI) and machine learning (ML) have therefore become central to multi-omics data analysis [208]. Traditional statistical methods are increasingly complemented or replaced by data-driven approaches such as deep learning and graph neural networks, which can jointly model nonlinear relationships across omics modalities and improve predictive accuracy for disease classification and phenotype inference [207].
However, many AI methods suffer from limited interpretability—a barrier to clinical translation. To address this, explainable AI (xAI) strategies have been developed to make model decisions transparent and biologically meaningful. xAI frameworks can highlight key molecular features driving predictions, making complex models accessible to domain experts and enhancing trust in actionable insights for clinical and systems biology applications [209].
Predictive modeling represents another critical frontier in integrative omics. Here, machine learning models are trained not simply to describe data but to forecast biological outcomes, such as disease onset, progression, or treatment response [210,211]. Integration of multi-omics profiles with ML systems has demonstrated improved predictive performance in cancer survival analyses, personalized immunotherapy response predictions, and multi-scale genotype–phenotype modeling [212].
The future of integrative omics lies in scalable, interpretable, and AI-driven frameworks capable of assimilating complex multi-layer biological information while maintaining biological relevance and clinical utility. Continued innovation in explainable machine learning, coupled with rigorous experimental design and data harmonization standards, will be essential for translating multi-omics integration into robust predictive tools for biomedical, ecological, and biotechnological applications [213].

10. Limitations and Future Directions

Beyond technical challenges, economic feasibility represents a major limitation for large-scale omics integration. High-throughput sequencing, multi-omics profiling, and advanced computational infrastructure entail substantial costs, which may limit accessibility across research settings. The implementation of integrative omics frameworks will therefore depend on collaborative infrastructures, shared data platforms, and international research consortia. Over time, technological scaling and cost reduction—similar to trends observed in genome sequencing—may improve accessibility.
Despite remarkable progress in omics technologies and their applications across biology and medicine, several key limitations continue to constrain the full realization of a systems-level understanding of living organisms [13].
First, temporal and spatial resolution remain a significant challenge. Most traditional omics approaches capture static snapshots of molecular states, providing limited insight into the dynamic changes that occur over time or within the complex architecture of tissues [186]. Although single-cell and spatial omics methods have enhanced resolution, their temporal profiling capabilities are still emergent and often constrained by technical and analytical limitations (e.g., sampling throughput and live-cell compatibility) [6,214].
Second, integration across biological scales—from molecular to cellular to tissue levels—remains computationally challenging. Multi-omics datasets exhibit considerable heterogeneity in data types, distribution, and dimensionality, requiring advanced algorithms for harmonization. While machine learning and network-based integration methods have made strides, issues such as missing data, batch effects, and interpretability continue to impede robust cross-layer synthesis [215,216]. Furthermore, many integrative models prioritize predictive performance over mechanistic interpretability, limiting biological insight.
Third, a range of emerging and speculative omics concepts—including signalomics, conformomics, electromomics, and others—have been proposed, yet their experimental validation is largely absent. The practical implementation of these conceptual omics awaits technological innovations capable of capturing the relevant phenomena with sufficient sensitivity and resolution [13,216]. For example, experimentally characterizing intracellular electromagnetic fields or biologically meaningful vibrational states will require new sensing modalities beyond the current state of the art.
Finally, while the integration of multi-omics data offers transformative potential, conceptual expansion is essential to advance the field. Frameworks such as adaptomics, resiliomics, chrono-adaptomics, and plasticomics provide novel perspectives on biological adaptation, resilience, temporal modulation, and plasticity that extend beyond static measurement. These conceptual layers emphasize dynamic processes and system behavior, opening new avenues for understanding how organisms respond to environmental, developmental, and stochastic influences. However, realizing their potential will depend on developing appropriate experimental designs, longitudinal sampling strategies, and computational models capable of capturing dynamic trajectories [206,216].
In summary, although fundamental and advanced omics technologies have expanded our ability to observe and characterize life at multiple scales, significant methodological, computational, and conceptual challenges remain. Addressing these limitations will require interdisciplinary collaboration, sustained innovation in both experimental and computational domains, and a willingness to develop new theoretical frameworks that embrace complexity and dynamics.
It is important to emphasize that many conceptual omics frameworks described in this review represent long-term perspectives rather than immediately implementable technologies. Their value lies in guiding future research directions and providing integrative conceptual models for complex biological systems.

11. Conclusions

This review highlights that omics sciences are evolving from descriptive molecular cataloging toward dynamic, integrative, and predictive frameworks. A key conclusion is that future progress will depend not only on technological advancements but also on the development of conceptual models capable of integrating temporal dynamics, spatial organization, and system-level regulation.
Emerging frameworks such as adaptomics, resiliomics, signalomics, and bioenergetic omics illustrate a shift toward understanding biological systems as adaptive, energy-constrained, and information-processing entities. However, these concepts remain largely theoretical and require experimental validation.
Another major conclusion is that multi-omics integration, while powerful, remains limited by computational challenges, data heterogeneity, and lack of interpretability. Advances in explainable artificial intelligence and longitudinal experimental design will be essential to overcome these barriers.
Overall, the future of omics sciences lies in bridging molecular data with dynamic system behavior, enabling predictive and mechanistic insights across biological scales. A key priority for future research will be the operationalization of conceptual omics into measurable frameworks supported by experimental and computational advances.

Funding

This research received no external funding.

Data Availability Statement

No new data were created or analyzed in this study. This article is based on previously published studies, which are cited within the manuscript. All relevant information is contained within the article.

Acknowledgments

The author would like to acknowledge Latifa Chehab, Sarra Roubi, Juan Pablo Fernández-Trujillo from Universidad Politécnica de Cartagena and Allal Douira from Ibn Tofail University for their continued support.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

AIArtificial Intelligence
ATPAdenosine Triphosphate
ChIP-seqChromatin Immunoprecipitation Sequencing
CO2Carbon Dioxide
DNADeoxyribonucleic Acid
GC-MSGas Chromatography–Mass Spectrometry
LC-MSLiquid Chromatography–Mass Spectrometry
mRNAMessenger RNA
NGSNext-Generation Sequencing
NMRNuclear Magnetic Resonance
PTMsPost-Translational Modifications
RNARibonucleic Acid
RNA-seqRNA Sequencing
scRNA-seqSingle-Cell RNA Sequencing
Adaptomics (ADP)Study of dynamic biological adaptation
Anthropomics (ANT)Impact of human activities on biological systems
Chrono-adaptomics (CAD)Temporal dynamics of adaptation
Climatonomics (CLM)Biological responses to climate variables
Conformomics (CNF)Biomolecular conformational dynamics
Decisiomics (DEC)Cellular decision-making processes
Electromomics (ELM)Intracellular electromagnetic fields (hypothetical)
Energomics (ENG)Cellular energy fluxes (conceptual)
Fluxomics (FLX)Metabolic flux analysis
Genomics (GEN)Study of genomes
Interactomics (INT)Molecular interaction networks
Metabolomics (MET)Small molecule/metabolite profiling
Microbiomics (MIC)Microbial community analysis
Plasticomics (PLA)Molecular plasticity and cellular memory
Proteomics (PRO)Protein profiling
Resiliomics (RES)Biological resilience and recovery
Signalomics (SIG)Cellular signaling dynamics
Spatial omics (SPO)Spatially resolved molecular profiling
Stochastomics (STO)Biological variability and noise
Transcriptomics (TRA)RNA expression profiling
Vibratomics (VIB)Molecular vibration analysis (speculative)

References

  1. Reon, B.J.; Dutta, A. Biological processes discovered by high-throughput sequencing. Am. J. Pathol. 2016, 186, 722–732. [Google Scholar] [CrossRef]
  2. Zarid, M. Integrated omics reveal genetic and environmental regulation of texture and aroma in melon fruit. J. Genome Biotechnol. Genet. 2026, 1, 2. [Google Scholar] [CrossRef]
  3. Song, D.; Zhang, J.; Zhou, J.; Yuan, X.; Tang, L.; Sun, K.; Shi, Q.; Sun, H.; Zhao, W. The progress and prospects of single-cell sequencing, multi-omics integration analysis, and immunotherapy targeting strategies in lung cancer research. Curr. Proteom. 2025, 22, 100060. [Google Scholar] [CrossRef]
  4. Vitorino, R. Transforming clinical research: The power of high-throughput omics integration. Proteomes 2024, 12, 25. [Google Scholar] [CrossRef]
  5. Kumar, R.; Kumar, M.; Chaudhary, V.; Teotia, S.; Singh, D. Exploring recent advances, limitations, and future prospects of OMICS-based technologies in plant–pathogen interaction studies: A systematic review. Discov. Plants 2025, 2, 284. [Google Scholar] [CrossRef]
  6. Liu, Y.; Molchanov, V.; Brass, D.; Yang, T. Recent advances in omics and the integration of multi-omics in osteoarthritis research. Arthritis Res. Ther. 2025, 27, 100. [Google Scholar] [CrossRef] [PubMed]
  7. Zarid, M. Introgression and environmental effects on gene expression and aroma volatiles as biomarkers in a melon near-isogenic line. J. Biotechnol. Biores. 2023, 4, 596. [Google Scholar] [CrossRef]
  8. Canales, I.; Fernández-Trujillo, J.P.; Bueso, M.C.; Zarid, M. Volatile changes in non-climacteric melons with introgression in linkage group X at three stages of maturity. Acta Hortic. 2016, 1194, 351–356. [Google Scholar] [CrossRef]
  9. Escudero, A.A.; Zarid, M.; Bueso, M.C.; Fernández-Trujillo, J.P. Aroma volatiles during non-climacteric melon ripening and potential association with flesh firmness. Acta Hortic. 2016, 1194, 363–366. [Google Scholar] [CrossRef]
  10. Inayatullah, M.; Dwivedi, A.K.; Tiwari, V.K. Advances in single-cell omics: Transformative applications in basic and clinical research. Curr. Opin. Cell Biol. 2025, 95, 102548. [Google Scholar] [CrossRef] [PubMed]
  11. Liu, X.; Peng, T.; Xu, M.; Lin, S.; Hu, B.; Chu, T.; Liu, B.; Xu, Y.; Ding, W.; Li, L.; et al. Spatial multi-omics: Deciphering technological landscape of integration of multi-omics and its applications. J. Hematol. Oncol. 2024, 17, 72. [Google Scholar] [CrossRef]
  12. Morabito, A.; De Simone, G.; Pastorelli, R.; Brunelli, L.; Ferrario, M. Algorithms and tools for data-driven omics integration to achieve multilayer biological insights: A narrative review. J. Transl. Med. 2025, 23, 425. [Google Scholar] [CrossRef]
  13. Dai, X.; Shen, L. Advances and trends in omics technology development. Front. Med. 2022, 9, 911861. [Google Scholar] [CrossRef]
  14. Zarid, M. Postharvest physiology, genome sequencing and QTL mapping of melon: A review. J. Agric. Sci. Technol. A 2017, 7, 441–455. [Google Scholar] [CrossRef]
  15. Manzoni, C.; Kia, D.A.; Vandrovcova, J.; Hardy, J.; Wood, N.W.; Lewis, P.A.; Ferrari, R. Genome, transcriptome and proteome: The rise of omics data and their integration in biomedical sciences. Brief. Bioinform. 2018, 19, 286–302. [Google Scholar] [CrossRef]
  16. Liu, Y.; Dai, Y.; Wang, L. Spatial omics at the forefront: Emerging technologies, analytical innovations, and clinical applications. Cancer Cell 2026, 44, 24–49. [Google Scholar] [CrossRef]
  17. Sibilio, P.; De Smaele, E.; Paci, P.; Conte, F. Integrating multi-omics data: Methods and applications in human complex diseases. Biotechnol. Rep. 2025, 48, e00938. [Google Scholar] [CrossRef] [PubMed]
  18. Zarid, M.; García-Carpintero, V.; Esteras, C.; Esteva, J.; Bueso, M.C.; Cañizares, J.; Picó, M.B.; Monforte, A.J.; Fernández-Trujillo, J.P. Transcriptomic analysis of a near-isogenic line of melon with higher fruit flesh firmness during ripening. J. Sci. Food Agric. 2021, 101, 754–777. [Google Scholar] [CrossRef] [PubMed]
  19. Hardy, B.J.; Khan, S.E.A.; Daar, A.S. Genomics. In Encyclopedia of Global Bioethics; ten Have, H., Ed.; Springer: Cham, Switzerland, 2015. [Google Scholar] [CrossRef]
  20. Zarid, M. A multi-omics perspective on the environmental and genetic regulation of melon. In Plants2025: From Seeds to Food Security; MDPI: Basel, Switzerland, 2025. [Google Scholar]
  21. Auton, A.; Brooks, L.D.; Durbin, R.M.; Garrison, E.P.; Kang, H.M.; Korbel, J.O.; Marchini, J.L.; McCarthy, S.; McVean, G.A.; Abecasis, G.R. A global reference for human genetic variation. Nature 2015, 526, 68–74. [Google Scholar] [CrossRef] [PubMed]
  22. Zhang, F.; Gu, W.; Hurles, M.E.; Lupski, J.R. Copy number variation in human health, disease, and evolution. Annu. Rev. Genom. Hum. Genet. 2009, 10, 451–481. [Google Scholar] [CrossRef]
  23. Song, X.; Fan, B.L.; Hong, X.; Su, P.; Sun, M. Unveiling plant metabolic diversity: Integrating metabolomics with multi-omics approaches for crop improvement. Plants 2026, 15, 846. [Google Scholar] [CrossRef] [PubMed]
  24. Cao, Y.; Yan, J.; Ross-Ibarra, J.; Yang, N. Plant domestication revisited: Genomic insights into origins, mechanisms, and convergent evolution. iScience 2026, 29, 114062. [Google Scholar] [CrossRef] [PubMed]
  25. Sarfraz, Z.; Zarlashat, Y.; Ambreen, A.; Mujahid, M.; Iqbal, M.; Fatima, S.; Iqbal, M.; Iqbal, R.; Fiaz, S. Plant biochemistry in the era of omics: Integrated omics approaches to unravel the genetic basis of plant stress tolerance. Plant Breed. 2025, 1–23. [Google Scholar] [CrossRef]
  26. Zarid, M. Association Among Aroma Volatiles and Other Traits in One Near-Isogenic Line with Firm Flesh Texture. Ph.D. Thesis, Universidad Politécnica de Cartagena, Cartagena, Spain, 2020. [Google Scholar] [CrossRef]
  27. Li, X.; Li, Y.; Sun, Y.; Li, S.; Cai, Q.; Li, S.; Sun, M.; Yu, T.; Meng, X.; Zhang, J. Integrating genetic diversity and agronomic innovations for climate-resilient maize systems. Plants 2025, 14, 1552. [Google Scholar] [CrossRef]
  28. Mishra, A.; Singh, R.K. Crop genomics: A tool for crop improvement. In Crop Genomics: A Tool for Crop Improvement; CABI: Wallingford, UK, 2025; pp. 32–43. [Google Scholar] [CrossRef]
  29. Kong, W.; Kong, X.; Xia, Z.; Li, X.; Wang, F.; Shan, R.; Chen, Z.; You, X.; Zhao, Y.; Hu, Y.; et al. Genomic analysis of 1325 Camellia accessions sheds light on agronomic and metabolic traits for tea plant improvement. Nat. Genet. 2025, 57, 997–1007. [Google Scholar] [CrossRef]
  30. Zarid, M.; Esteras, C.; Sifres, A.G.; Cañizares, X.; Esteva, J.; Bueso, M.C.; Picó, M.B.; Monforte, A.J.; Fernández-Trujillo, J.P. Lower relative differential expression of two genes is associated with delayed ripening in melon. In Proceedings of the 8th Workshop on Agri-Food Research for Young Researchers; Universidad Politécnica de Cartagena: Cartagena, Spain, 2020. [Google Scholar] [CrossRef]
  31. Zarid, M.; Esteras, C.; Sifres, A.G.; Cañizares, X.; Esteva, J.; Picó, M.B.; Monforte, A.J.; Fernández-Trujillo, J.P. High relative expression of two genes of a melon near-isogenic line versus its parental during ripening. In Proceedings of the 7th Workshop on Agri-Food Research; Universidad Politécnica de Cartagena: Cartagena, Spain, 2019. [Google Scholar] [CrossRef]
  32. Zarid, M.; Esteras, C.; Sifres, A.G.; Cañizares, X.; Esteva, J.; Picó, M.B.; Monforte, A.J.; Fernández-Trujillo, J.P. Gene expression and volatile production during melon ripening. In Proceedings of the 6th Workshop on Agri-Food Research; Universidad Politécnica de Cartagena: Murcia, Spain, 2017; pp. 27–30. [Google Scholar] [CrossRef]
  33. Jain, A.; Sarsaiya, S.; Singh, R.; Gong, Q.; Wu, Q.; Shi, J. Omics approaches in understanding the benefits of plant–microbe interactions. Front. Microbiol. 2024, 15, 1391059. [Google Scholar] [CrossRef]
  34. Martínez-Campos, C.; Lanz-Mendoza, H.; Cime-Castillo, J.A.; Peralta-Zaragoza, Ó.; Madrid-Marina, V. RNA through time: From the origin of life to therapeutic frontiers in transcriptomics and epitranscriptional medicine. Int. J. Mol. Sci. 2025, 26, 4964. [Google Scholar] [CrossRef]
  35. Lowe, R.; Shirley, N.; Bleackley, M.; Dolan, S.; Shafee, T. Transcriptomics technologies. PLoS Comput. Biol. 2017, 13, e1005457. [Google Scholar] [CrossRef]
  36. Kalantari-Dehaghi, M.; Ghohabi-Esfahani, N.; Emadi-Baygi, M. From bulk RNA sequencing to spatial transcriptomics: A comparative review of differential gene expression analysis methods. Hum. Genom. 2025, 20, 9. [Google Scholar] [CrossRef]
  37. Getnet, M.D.; Godana, B.A. Advancements in single-cell RNA sequencing and spatial transcriptomics: Transforming biomedical research. Acta Biochim. Pol. 2025, 72, 13922. [Google Scholar] [CrossRef]
  38. Wang, H.; Cheng, P.; Wang, J.; Lv, H.; Han, J.; Hou, Z.; Xu, R.; Chen, W. Advances in spatial transcriptomics and its application in the musculoskeletal system. Bone Res. 2025, 13, 54. [Google Scholar] [CrossRef]
  39. Anderson, A.C.; Yanai, I.; Yates, L.R.; Wang, L.; Swarbrick, A.; Sorger, P.; Santagata, S.; Fridman, W.H.; Gao, Q.; Jerby, L.; et al. Spatial transcriptomics. Cancer Cell 2022, 40, 895–900. [Google Scholar] [CrossRef]
  40. Yousef, N.; Wu, W.; Alajaji, S.; Mahadevan, A.; Sultan, A.S.; Molloy, E.K.; Nguyen, J.T. Spatial transcriptomics and artificial intelligence: A scoping review of emerging applications in head and neck pathology. Head Neck Pathol. 2026, 20, 26. [Google Scholar] [CrossRef] [PubMed]
  41. Hatoum, F.; Fazili, A.; Miller, J.W.; Wang, X.; Yu, X.; Lu, X.; Johnson, J.S.; Spiess, P.E.; Chahoud, J. Current role and future frontiers of spatial transcriptomics in genitourinary cancers. Cancers 2025, 17, 2774. [Google Scholar] [CrossRef] [PubMed]
  42. Zarid, M. The dilemma of food genetics and improvement. Open Life Sci. 2025, 20, 20251150. [Google Scholar] [CrossRef]
  43. Delos Santos, K.; Rockel, J.S.; Kapoor, M. Spatial transcriptomics: Challenges and future directions in musculoskeletal diseases. Curr. Opin. Rheumatol. 2026, 38, 143–153. [Google Scholar] [CrossRef]
  44. Fu, L.; Wang, P.; Xu, G.; Lu, J.; Peng, Q.; Wu, D.; Sun, H. S3RL: Enhancing spatial single-cell transcriptomics with separable representation learning. Adv. Sci. 2026, 13, e16178. [Google Scholar] [CrossRef] [PubMed]
  45. Yang, J.; Zheng, Z.; Jiao, Y.; Yu, K.; Bhatara, S.; Yang, X.; Natarajan, S.; Zhang, J.; Pan, Q.; Easton, J.; et al. Spotiphy enables single-cell spatial whole transcriptomics across an entire section. Nat. Methods 2025, 22, 724–736. [Google Scholar] [CrossRef]
  46. Xie, M.; Wang, J.; Wang, F.; Wang, J.; Yan, Y.; Feng, K.; Chen, B. A review of genomic, transcriptomic, and proteomic applications in edible fungi biology: Current status and future directions. J. Fungi 2025, 11, 422. [Google Scholar] [CrossRef]
  47. Fang, Z.; Zhang, Y.; Feng, X.; Li, N.; Chen, L.; Zhan, X. Proteoformics: Current status and future perspectives. J. Proteom. 2025, 321, 105524. [Google Scholar] [CrossRef]
  48. Dogiparthi, L.K.; Bukke, S.P.N.; Thalluri, C.; Thalamanchi, B.; Vidya, K.P.; Sree, G.N.; Tatiparthi, H.; Uppicherla, D.; Thummaginjala, K.P. The role of genomics and proteomics in drug discovery and its application in pharmacy. Discov. Appl. Sci. 2025, 7, 552. [Google Scholar] [CrossRef]
  49. Xu, Z.; Wang, C.; Zhang, Z.; Wang, H.; Gao, P.; Weng, L. Engineered protein modification: A new paradigm for enhancing biosensing sensitivity and diagnostic accuracy. Biosensors 2025, 16, 21. [Google Scholar] [CrossRef] [PubMed]
  50. Lehe, M.D.; Almofeez, R.; Jeffery, E.D.; Sheynkman, G.M. Advances in mass spectrometry instrumentation and methodology for analysis of alternative protein isoforms. J. Mass Spectrom. 2026, 61, e70024. [Google Scholar] [CrossRef]
  51. Qiu, S.; Cai, Y.; Yao, H.; Lin, C.; Xie, Y.; Tang, S.; Zhang, A. Small molecule metabolites: Discovery of biomarkers and therapeutic targets. Signal Transduct. Target. Ther. 2023, 8, 132. [Google Scholar] [CrossRef]
  52. Patti, G.J.; Yanes, O.; Siuzdak, G. Innovation: Metabolomics: The apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 2012, 13, 263–269. [Google Scholar] [CrossRef] [PubMed]
  53. Gallart-Ayala, H.; Teav, T.; Ivanisevic, J. Metabolomics meets lipidomics: Assessing the small molecule component of metabolism. BioEssays 2020, 42, e2000052. [Google Scholar] [CrossRef] [PubMed]
  54. Zarid, M.; Bueso, M.C.; Fernández-Trujillo, J.P. Seasonal effects on flesh volatile concentrations and texture at harvest in a near-isogenic line of melon with introgression in LG X. Sci. Hortic. 2020, 266, 109244. [Google Scholar] [CrossRef]
  55. Emwas, A.H.; Roy, R.; McKay, R.T.; Tenori, L.; Saccenti, E.; Gowda, G.A.N.; Raftery, D.; Alahmari, F.; Jaremko, L.; Jaremko, M.; et al. NMR spectroscopy for metabolomics research. Metabolites 2019, 9, 123. [Google Scholar] [CrossRef]
  56. Homobono Brito de Moura, P.; Leleu, G.; Da Costa, G.; Marti, G.; Pétriacq, P.; Valls Fonayet, J.; Richard, T. Integrating NMR and MS for improved metabolomic analysis: From methodologies to applications. Molecules 2025, 30, 2624. [Google Scholar] [CrossRef]
  57. Stark, C.; Jenison, S.E.; Ngo, M.T. Omics approaches to study and model cell–cell interactions in engineered tissues. Front. Chem. Eng. 2025, 7, 1629455. [Google Scholar] [CrossRef]
  58. Gutierrez Reyes, C.D.; Alejo-Jacuinde, G.; Perez Sanchez, B.; Chavez Reyes, J.; Onigbinde, S.; Mogut, D.; Hernández-Jasso, I.; Calderón-Vallejo, D.; Quintanar, J.L.; Mechref, Y. Multi-omics applications in biological systems. Curr. Issues Mol. Biol. 2024, 46, 5777–5793. [Google Scholar] [CrossRef]
  59. Rao, G.H.R. Embracing the multifaceted roles of biomolecules in biology and medicine. Biomolecules 2025, 15, 1636. [Google Scholar] [CrossRef]
  60. Liu, X.; Abad, L.; Chatterjee, L.; Cristea, I.M.; Varjosalo, M. Mapping protein–protein interactions by mass spectrometry. Mass Spectrom. Rev. 2026, 45, 69–106. [Google Scholar] [CrossRef]
  61. Yang, X.; Cui, W.; Wang, L.; Zheng, Y. A brief progress in methods for deciphering protein–protein interaction networks. Int. J. Mol. Sci. 2026, 27, 1844. [Google Scholar] [CrossRef]
  62. Vidal, M.; Cusick, M.E.; Barabási, A.-L. Interactome networks and human disease. Cell 2011, 144, 986–998. [Google Scholar] [CrossRef] [PubMed]
  63. Wang, Q.; Dong, A.; Jiang, L.; Griffin, C.; Wu, R. A single-cell omics network model of cell crosstalk during the formation of primordial follicles. Cells 2022, 11, 332. [Google Scholar] [CrossRef] [PubMed]
  64. Shahzaib, M.; Aprile, D.; Squillaro, T.; Alessio, N.; Peluso, G.; Di Bernardo, G.; Galderisi, U. The interactome era: Integrating RNA-seq, proteomics, and network biology to decode cellular senescence. Ageing Res. Rev. 2026, 113, 102916. [Google Scholar] [CrossRef] [PubMed]
  65. Bouhaddou, M.; Eckhardt, M.; Chi Naing, Z.Z.; Kim, M.; Ideker, T.; Krogan, N.J. Mapping the protein–protein and genetic interactions of cancer to guide precision medicine. Curr. Opin. Genet. Dev. 2019, 54, 110–117. [Google Scholar] [CrossRef]
  66. Kuzu, O.F.; Granerud, L.J.T.; Saatcioglu, F. Navigating the landscape of protein folding and proteostasis: From molecular chaperones to therapeutic innovations. Signal Transduct. Target. Ther. 2025, 10, 358. [Google Scholar] [CrossRef]
  67. Gerritsen, J.S.; White, F.M. Phosphoproteomics: A valuable tool for uncovering molecular signaling in cancer cells. Expert Rev. Proteom. 2021, 18, 661–674. [Google Scholar] [CrossRef]
  68. Dakup, P.P.; Feng, S.; Shi, T.; Jacobs, J.M.; Wiley, H.S.; Qian, W.-J. Targeted quantification of protein phosphorylation and its contributions towards mathematical modeling of signaling pathways. Molecules 2023, 28, 1143. [Google Scholar] [CrossRef] [PubMed]
  69. Xiao, D.; Chen, C.; Yang, P. Computational systems approach towards phosphoproteomics and their downstream regulation. Proteomics 2023, 23, e2200068. [Google Scholar] [CrossRef] [PubMed]
  70. Onigbinde, S.; Adeniyi, M.; Daramola, O.; Chukwubueze, F.; Bhuiyan, M.M.A.A.; Nwaiwu, J.; Bhattacharjee, T.; Mechref, Y. Glycomics in human diseases and its emerging role in biomarker discovery. Biomedicines 2025, 13, 2034. [Google Scholar] [CrossRef]
  71. Fu, B.; Chen, J.; Liu, X.; Li, J.; Feng, X.; Wang, J.; Li, Y.; Zhang, Y.; Ma, J.; Wang, Y.; et al. Large-scale serum N-glycomics tracks N-glycosylation dynamics in hepatocellular carcinoma progression and enables early diagnosis. Nat. Commun. 2026, 17, 1885. [Google Scholar] [CrossRef] [PubMed]
  72. Miao, X.; Deng, J.; Cai, F.; Ling, Y.; Li, L.; Zhang, Y.; Yang, S. Beyond the genome: GlycoRNAs as a nexus of glycobiology and RNA biology. Glycosci. Ther. 2026, 2, 100038. [Google Scholar] [CrossRef]
  73. Hornemann, T. Lipidomics in biomarker research. In Prevention and Treatment of Atherosclerosis; von Eckardstein, A., Binder, C.J., Eds.; Springer: Cham, Switzerland, 2021; Volume 270. [Google Scholar] [CrossRef]
  74. Shevchenko, A.; Simons, K. Lipidomics: Coming to grips with lipid diversity. Nat. Rev. Mol. Cell Biol. 2010, 11, 593–598. [Google Scholar] [CrossRef]
  75. Wu, Z.; Bagarolo, G.I.; Thoröe-Boveleth, S.; Jankowski, J. Lipidomics: Mass spectrometric and chemometric analyses of lipids. Adv. Drug Deliv. Rev. 2020, 159, 294–307. [Google Scholar] [CrossRef]
  76. Cho, Y.K.; Lee, S.; Lee, J.; Doh, J.; Park, J.H.; Jung, Y.S.; Lee, Y.H. Lipid remodeling of adipose tissue in metabolic health and disease. Exp. Mol. Med. 2023, 55, 1955–1973. [Google Scholar] [CrossRef]
  77. Fu, B.; Chen, J.; Liu, X.; Li, J.; Feng, X.; Wang, J.; Li, Y.; Zhang, Y.; Ma, J.; Wang, Y.; et al. Lipid metabolism in homeostasis and disease. Signal Transduct. Target. Ther. 2026, 11, 55. [Google Scholar] [CrossRef]
  78. Pashay Ahi, E.; House, A.H. Signaling pathways shaping the field of lipidomics. Prostaglandins Other Lipid Mediat. 2026, 182, 107053. [Google Scholar] [CrossRef]
  79. Mazhibiyeva, A.; Pham, T.T.; Pats, K.; Lukac, M.; Molnár, F. Bridging prediction and reality: Comprehensive analysis of experimental and AlphaFold2 full-length nuclear receptor structures. Comput. Struct. Biotechnol. J. 2025, 27, 1998–2013. [Google Scholar] [CrossRef]
  80. Wu, T.; Stein, R.A.; Kao, T.Y.; Brown, B.; Mchaourab, H.S. Modeling protein conformational ensembles by guiding AlphaFold2 with double electron–electron resonance (DEER) distance distributions. Nat. Commun. 2025, 16, 7107. [Google Scholar] [CrossRef]
  81. Borkakoti, N.; Thornton, J.M. AlphaFold2 protein structure prediction: Implications for drug discovery. Curr. Opin. Struct. Biol. 2023, 78, 102526. [Google Scholar] [CrossRef] [PubMed]
  82. Bertoline, L.M.F.; Lima, A.N.; Krieger, J.E.; Teixeira, S.K. Before and after AlphaFold2: An overview of protein structure prediction. Front. Bioinform. 2023, 3, 1120370. [Google Scholar] [CrossRef] [PubMed]
  83. Lesovoy, D.; Roshchin, K.; Sala, B.M.; Sandalova, T.; Achour, A.; Agback, T.; Agback, P.; Orekhov, V. Accurate protein dynamic conformational ensembles: Combining AlphaFold, MD, and amide 15N(1H) NMR relaxation. Int. J. Mol. Sci. 2025, 26, 8917. [Google Scholar] [CrossRef] [PubMed]
  84. Maiti, K.S. Two-dimensional infrared spectroscopy reveals better insights of structure and dynamics of protein. Molecules 2021, 26, 6893. [Google Scholar] [CrossRef]
  85. Luyet, C.; Elvati, P.; Vinh, J.; Violi, A. Low-THz vibrations of biological membranes. Membranes 2023, 13, 139. [Google Scholar] [CrossRef]
  86. Fels, D. The possible functions of electromagnetic cell communication. In Ultra-Weak Photon Emission from Biological Systems; Volodyaev, I., van Wijk, E., Cifra, M., Vladimirov, Y.A., Eds.; Springer: Cham, Switzerland, 2023. [Google Scholar] [CrossRef]
  87. Akabuogu, E.; Carneiro da Cunha Martorelli, V.; Krašovec, R.; Roberts, I.S.; Waigh, T.A. Emergence of ion-channel-mediated electrical oscillations in Escherichia coli biofilms. eLife 2025, 13, RP92525. [Google Scholar] [CrossRef]
  88. Ban, K.Y.; Na, Y.W.; Song, J.; Kim, J.S.; Kim, J. Protein–RNA interaction dynamics reveal key regulators of oncogenic KRAS-driven cancers. Sci. Rep. 2024, 14, 27119. [Google Scholar] [CrossRef]
  89. Yi, W.; Yan, J. Decoding RNA–protein interactions: Methodological advances and emerging challenges. Adv. Genet. 2025, 6, 2500011. [Google Scholar] [CrossRef]
  90. Ushakumary, M.G.; Sontag, R.L.; Posso, C.; Fillmore, T.L.; Topping, M.E.; Olson, H.M.; De Jager, P.L.; Bennett, D.A.; Arvanitakis, Z.; Petyuk, V.A. Phosphoproteomics unveils the signaling dynamics in neuronal cells stimulated with insulin and insulin-like growth factors. Cell Commun. Signal. 2025, 24, 27. [Google Scholar] [CrossRef] [PubMed]
  91. Gaizley, E.J.; Surinova, S. The pursuit of ultrasensitive phosphoproteomics to unravel signalling in rare cells. Commun. Biol. 2025, 8, 1738. [Google Scholar] [CrossRef] [PubMed]
  92. Muneer, G.; Chen, C.-S.; Chen, Y.-J. Advancements in global phosphoproteomics profiling: Overcoming challenges in sensitivity and quantification. Proteomics 2025, 25, e202400087. [Google Scholar] [CrossRef] [PubMed]
  93. Wu, Y.; Yang, M.; Xu, Y.; Jia, L.; Li, J.; Wang, X.; Zhao, J.; Cai, Y.; Zhang, Y.; Sun, S. A comprehensive N-glycoproteome atlas reveals tissue-specific glycan remodeling but non-random structural microheterogeneities. Nat. Commun. 2026, 17, 1448. [Google Scholar] [CrossRef]
  94. Onigbinde, S.; Solomon, J.; Gutierrez-Reyes, C.D.; Daramola, O.; Fowowe, M.; Adeniyi, M.; DuBois, K.N.; Bakulski, K.M.; Kanaan, N.M.; Lubman, D.M.; et al. Serum N-glycan profiling identifies candidate glycan biomarkers for early detection and prediction of Alzheimer’s disease. J. Proteome Res. 2025, 24, 4417–4436. [Google Scholar] [CrossRef]
  95. Hu, C.; Shi, X.; Liu, X. New analytical techniques and applications of metabolomics and lipidomics. Metabolites 2026, 16, 63. [Google Scholar] [CrossRef]
  96. Song, P.; Wu, Y.; Zhang, C.; Zhou, F.; Bai, L.; Su, J. Materiobiology in the omics era. Mater. Today Bio 2025, 35, 102539. [Google Scholar] [CrossRef]
  97. Yang, X.; Xie, B.; Shen, P.; Chen, Y.; Li, C.; Tan, F.; Yang, Y.; Yang, Y.; Song, R.; Mi, P.; et al. Integrated multi-omic atlas reveals the hierarchy of spatiotemporal regulatory networks of mouse gastrulation. Nat. Commun. 2026, 17, 1572. [Google Scholar] [CrossRef]
  98. Lindtner, R.; Kampik, L.; Putzer, D.; Klosterhuber, M.; Pallua, A.K.; Streif, W.; Schirmer, M.; Degenhart, G.; Arora, R.; Pallua, J.D. Advancements in high-resolution computed tomography: Revolutionising bone health micro-research. Bioengineering 2025, 12, 1189. [Google Scholar] [CrossRef]
  99. Moradi Kashkooli, F.; Zhan, W.; Bhandari, A.; Yusufaly, T.I.; Kolios, M.C.; Rahmim, A.; Soltani, M. From images to physics-based computational models to digital twins: A framework for personalized cancer therapies. Front. Radiol. 2026, 6, 1737577. [Google Scholar] [CrossRef]
  100. Wang, K.C.; Chang, H.Y. Epigenomics: Technologies and applications. Circ. Res. 2018, 122, 1191–1199. [Google Scholar] [CrossRef]
  101. Kundaje, A.; Meuleman, W.; Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 2015, 518, 317–330. [Google Scholar] [CrossRef]
  102. Ma, S.; Zhang, Y. Profiling chromatin regulatory landscape: Insights into the development of ChIP-seq and ATAC-seq. Mol. Biomed. 2020, 1, 9. [Google Scholar] [CrossRef]
  103. Wagner, W. Epigenetic networks coordinate DNA methylation across the genome. Mol. Ther. 2025, 33, 4699–4713. [Google Scholar] [CrossRef]
  104. Gopi, L.K.; Kidder, B.L. Integrative pan-cancer analysis reveals epigenomic variation in cancer type and cell-specific chromatin domains. Nat. Commun. 2021, 12, 1419. [Google Scholar] [CrossRef]
  105. Maher, N.; Maiellaro, F.; Ghanej, J.; Rasi, S.; Moia, R.; Gaidano, G. Unraveling the epigenetic landscape of mature B cell neoplasia: Mechanisms, biomarkers, and therapeutic opportunities. Int. J. Mol. Sci. 2025, 26, 8132. [Google Scholar] [CrossRef]
  106. Gonzales, L.I.S.A.; Qiao, J.W.; Buffier, A.W.; Rogers, L.J.; Suchowerska, N.; McKenzie, D.R.; Kwan, A.H. An omics approach to delineating the molecular mechanisms that underlie the biological effects of physical plasma. Biophys. Rev. 2023, 4, 011312. [Google Scholar] [CrossRef]
  107. Guan, A.; Quek, C. Single-cell multi-omics: Insights into therapeutic innovations to advance treatment in cancer. Int. J. Mol. Sci. 2025, 26, 2447. [Google Scholar] [CrossRef]
  108. Landry, B.D.; Clarke, D.C.; Lee, M.J. Studying cellular signal transduction with omic technologies. J. Mol. Biol. 2015, 427, 3416–3440. [Google Scholar] [CrossRef]
  109. Wu, G.; Liang, Y.; Xi, Q.; Zuo, Y. New insights and implications of cell–cell interactions in developmental biology. Int. J. Mol. Sci. 2025, 26, 3997. [Google Scholar] [CrossRef]
  110. Bonsignore, F.; Pozzi, S.; Aloi, E.; Mazza, D.; Zambrano, S. Linking signaling dynamics and cell fate decisions through single-cell imaging: Evidence and challenges. Front. Cell Dev. Biol. 2025, 13, 1656051. [Google Scholar] [CrossRef]
  111. Haghverdi, L.; Ludwig, L.S. Single-cell multi-omics and lineage tracing to dissect cell fate decision-making. Stem Cell Rep. 2023, 18, 13–25. [Google Scholar] [CrossRef]
  112. Huang, B.; Lu, M.; Galbraith, M.; Levine, H.; Onuchic, J.N.; Jia, D. Decoding the mechanisms underlying cell-fate decision-making during stem cell differentiation by random circuit perturbation. J. R. Soc. Interface 2020, 17, 20200500. [Google Scholar] [CrossRef]
  113. Kucinski, I.; Wilson, N.K.; Hannah, R.; Kinston, S.J.; Cauchy, P.; Lenaerts, A.; Grosschedl, R.; Göttgens, B. Interactions between lineage-associated transcription factors govern haematopoietic progenitor states. EMBO J. 2020, 39, e104983. [Google Scholar] [CrossRef]
  114. Brown, G.; Sánchez, L.; Sánchez-García, I. Lineage decision-making within normal haematopoietic and leukemic stem cells. Int. J. Mol. Sci. 2020, 21, 2247. [Google Scholar] [CrossRef]
  115. Roeder, I.; Glauche, I. Towards an understanding of lineage specification in hematopoietic stem cells: A mathematical model for the interaction of transcription factors GATA-1 and PU.1. J. Theor. Biol. 2006, 241, 852–865. [Google Scholar] [CrossRef]
  116. Heffel, M.G.; Zhou, J.; Zhang, Y.; Lee, D.S.; Hou, K.; Pastor-Alonso, O.; Abuhanna, K.D.; Galasso, J.; Kern, C.; Tai, C.Y.; et al. Temporally distinct 3D multi-omic dynamics in the developing human brain. Nature 2024, 635, 481–489. [Google Scholar] [CrossRef]
  117. Reed, J.M.; Wolfe, B.E.; Romero, L.M. Is resilience a unifying concept for the biological sciences? iScience 2024, 27, 109478. [Google Scholar] [CrossRef]
  118. Yamada, H. Epigenetic clocks, resilience, and multi-omics ageing: A review and the EpiAge-R conceptual framework. Int. J. Mol. Sci. 2026, 27, 1908. [Google Scholar] [CrossRef]
  119. del Olmo, M.; Ector, C.; Herzel, H. Time after time—Circadian clocks through the lens of oscillator theory. FEBS Lett. 2026, 600, 808–836. [Google Scholar] [CrossRef]
  120. Williams, R., Jr.; Van Den Oord, C.; Lee, E.N.; Fedde, S.C.; Oscherwitz, G.L.; Ribic, A. Critical period plasticity is associated with resilience to short unpredictable stress. Front. Behav. Neurosci. 2025, 19, 1584240. [Google Scholar] [CrossRef]
  121. Del Giudice, M. Plasticity as a developing trait: Exploring the implications. Front. Zool. 2015, 12, S4. [Google Scholar] [CrossRef]
  122. Raj, A.; van Oudenaarden, A. Nature, nurture, or chance: Stochastic gene expression and its consequences. Cell 2008, 135, 216–226. [Google Scholar] [CrossRef]
  123. Zhang, Q.; Cao, W.; Wang, J.; Yin, Y.; Sun, R.; Tian, Z.; Hu, Y.; Tan, Y.; Zhang, B. Transcriptional bursting dynamics in gene expression. Front. Genet. 2024, 15, 1451461. [Google Scholar] [CrossRef]
  124. Narayan, A.; Berger, B.; Cho, H. Assessing single-cell transcriptomic variability through density-preserving data visualization. Nat. Biotechnol. 2021, 39, 765–774. [Google Scholar] [CrossRef]
  125. Smith, K.F.; Pochon, X.; Melvin, S.D.; Wheeler, T.T.; Tremblay, L.A. Integration of “omics”-based approaches in environmental risk assessment to establish cause-and-effect relationships: A review. Toxics 2025, 13, 714. [Google Scholar] [CrossRef]
  126. Zhan, A. Multi-omics-driven adaptive management of biological invasions: Toward a proactive, predictive, and integrative framework. Biol. Divers. 2025, 2, 163–192. [Google Scholar] [CrossRef]
  127. Ebner, J.N. Trends in the application of “omics” to ecotoxicology and stress ecology. Genes 2021, 12, 1481. [Google Scholar] [CrossRef]
  128. Varadharajan, V.; Rajendran, R.; Muthuramalingam, P.; Runthala, A.; Madhesh, V.; Swaminathan, G.; Murugan, P.; Srinivasan, H.; Park, Y.; Shin, H.; et al. Multi-omics approaches against abiotic and biotic stress: A review. Plants 2025, 14, 865. [Google Scholar] [CrossRef]
  129. Derbyshire, M.C.; Batley, J.; Edwards, D. Use of multiple omics techniques to accelerate the breeding of abiotic stress tolerant crops. Curr. Plant Biol. 2022, 32, 100262. [Google Scholar] [CrossRef]
  130. Roychowdhury, R.; Das, S.P.; Gupta, A.; Parihar, P.; Chandrasekhar, K.; Sarker, U.; Kumar, A.; Ramrao, D.P.; Sudhakar, C. Multi-omics pipeline and omics-integration approach to decipher plant’s abiotic stress tolerance responses. Genes 2023, 14, 1281. [Google Scholar] [CrossRef]
  131. Dutta, S.; Das, S.; Gorain, S.; Kundu, S.; Bera, M.; Roy Choudhury, M.; Bag, S.; Paswan Das, D. Unraveling anthropogenic and climate stressors in the Sundarbans and their ripple effects on livelihoods and ecosystems, and adaptation strategies for a sustainable future: A systematic review. Environ. Dev. 2026, 58, 101410. [Google Scholar] [CrossRef]
  132. Anderson, J.T.; Panetta, A.M.; Mitchell-Olds, T. Evolutionary and ecological responses to anthropogenic climate change. Plant Physiol. 2012, 160, 1728–1740. [Google Scholar] [CrossRef]
  133. Flores, C.; Millard, S.; Seekatz, A.M. Bridging ecology and microbiomes: Applying ecological theories in host-associated microbial ecosystems. Curr. Clin. Microbiol. Rep. 2025, 12, 9. [Google Scholar] [CrossRef]
  134. Li, S.; Chiodi, C.; Maucieri, C.; Della Lucia, M.C.; Zardinoni, G.; Ravi, S.; Squartini, A.; Concheri, G.; Geng, G.; Wang, Y.; et al. Profiling soil–plant–microbial communities: DNA and multi-omics techniques. Genes 2026, 17, 303. [Google Scholar] [CrossRef]
  135. Younas, M.U.; Zuo, S.; Qasim, M.; Ahmad, I.; Feng, Z.; Korai, S.K.; Zulfiqar, U.; Tukhtaboeva, F.; Ismoilov, I.; Malik, T. Multi-omics approaches in plant biology: Decoding agronomic traits for sustainable agriculture. Plant Stress 2025, 18, 101118. [Google Scholar] [CrossRef]
  136. Ossowicki, A.; Raaijmakers, J.M.; Garbeva, P. Disentangling soil microbiome functions by perturbation. Environ. Microbiol. Rep. 2021, 13, 582–590. [Google Scholar] [CrossRef]
  137. Qi, S.; Wang, J.; Zhang, Y.; Naz, M.; Afzal, M.R.; Du, D.; Dai, Z. Omics approaches in invasion biology: Understanding mechanisms and impacts on ecological health. Plants 2023, 12, 1860. [Google Scholar] [CrossRef]
  138. Weiskopf, S.R.; Rubenstein, M.A.; Crozier, L.G.; Gaichas, S.; Griffis, R.; Halofsky, J.E.; Hyde, K.J.W.; Morelli, T.L.; Morisette, J.T.; Muñoz, R.C.; et al. Climate change effects on biodiversity, ecosystems, ecosystem services, and natural resource management in the United States. Sci. Total Environ. 2020, 733, 137782. [Google Scholar] [CrossRef]
  139. Zeng, Q.; Hu, H.W.; Ge, A.H.; Xiong, C.; Zhai, C.C.; Duan, G.L.; Han, L.L.; Huang, S.Y.; Zhang, L.M. Plant–microbiome interactions and their impacts on plant adaptation to climate change. J. Integr. Plant Biol. 2025, 67, 826–844. [Google Scholar] [CrossRef]
  140. Fadiji, A.E.; Adeniji, A.; Lanrewaju, A.A.; Adedayo, A.A.; Chukwuneme, C.F.; Nwachukwu, B.C.; Aderibigbe, J.; Omomowo, I.O. Key challenges in plant microbiome research in the next decade. Microorganisms 2025, 13, 2546. [Google Scholar] [CrossRef]
  141. Thangaraj, S.; Sun, J. Omics insights into ocean health: Molecular adaptations and ecosystem resilience under climate stress. Adv. Clim. Change Res. 2026, 17, 199–217. [Google Scholar] [CrossRef]
  142. Senizza, B.; Araniti, F.; Lewin, S.; Wende, S.; Kolb, S.; Lucini, L. A multi-omics approach to unravel the interaction between heat and drought stress in Arabidopsis thaliana holobiont. Front. Plant Sci. 2024, 15, 1484251. [Google Scholar] [CrossRef] [PubMed]
  143. Amin, A.; Zaman, W.; Park, S. Harnessing multi-omics and predictive modeling for climate-resilient crop breeding: From genomes to fields. Genes 2025, 16, 809. [Google Scholar] [CrossRef]
  144. Nicotra, A.B.; Atkin, O.K.; Bonser, S.P.; Davidson, A.M.; Finnegan, E.J.; Mathesius, U.; Poot, P.; Purugganan, M.D.; Richards, C.L.; Valladares, F.; et al. Plant phenotypic plasticity in a changing climate. Trends Plant Sci. 2010, 15, 684–692. [Google Scholar] [CrossRef]
  145. Miryeganeh, M.; Armitage, D.W. Epigenetic responses of trees to environmental stress in the context of climate change. Biol. Rev. 2025, 100, 131–148. [Google Scholar] [CrossRef]
  146. Pazzaglia, J.; Reusch, T.B.H.; Terlizzi, A.; Marín-Guirao, L.; Procaccini, G. Phenotypic plasticity under rapid global changes: The intrinsic force for future seagrasses survival. Evol. Appl. 2021, 14, 1181–1201. [Google Scholar] [CrossRef]
  147. Mori, E.; Di Lorenzo, T.; Viviano, A.; Jakovljević, T.; Marra, E.; Moura, B.B.; Garosi, C.; Manzini, J.; Ancillotto, L.; Hoshika, Y.; et al. Under pressure: Environmental stressors in urban ecosystems and their ecological and social consequences on biodiversity and human well-being. Stresses 2025, 5, 66. [Google Scholar] [CrossRef]
  148. Zhang, X.; Wan, W.; Estoque, R.C. Impacts of urban and cropland expansions on natural habitats in Southeast Asia. Nat. Commun. 2025, 16, 8479. [Google Scholar] [CrossRef] [PubMed]
  149. Khan, S.; Ince-Dunn, G.; Suomalainen, A.; Elo, L.L. Integrative omics approaches provide biological and clinical insights: Examples from mitochondrial diseases. J. Clin. Investig. 2020, 130, 20–28. [Google Scholar] [CrossRef]
  150. Liu, X.; Li, F.; Czosnyka, M.; Czosnyka, Z.; Yu, H.; Tong, X.; Xing, Y.; Li, H.; Pu, K.; Feng, K.; et al. Multi-omics and high-spatial-resolution omics: Deciphering complexity in neurological disorders. Gigascience 2025, 14, giaf137. [Google Scholar] [CrossRef]
  151. Coppola, G. (Ed.) The OMICs: Applications in Neuroscience; Oxford University Press: New York, NY, USA, 2013. [Google Scholar] [CrossRef]
  152. Chen, C.; Wang, J.; Pan, D.; Wang, X.; Xu, Y.; Yan, J.; Wang, L.; Yang, X.; Yang, M.; Liu, G.P. Applications of multi-omics analysis in human diseases. MedComm 2023, 4, e315. [Google Scholar] [CrossRef]
  153. Yoon, J.H.; Lee, H.; Kwon, D.; Lee, D.; Lee, S.; Cho, E.; Kim, J.; Kim, D. Integrative approach of omics and imaging data to discover new insights for understanding brain diseases. Brain Commun. 2024, 6, fcae265. [Google Scholar] [CrossRef]
  154. Gao, J.; Zhang, C.; Wheelock, Å.M.; Xin, S.; Cai, H.; Xu, L.; Wang, X.J. Immunomics in one health: Understanding the human, animal, and environmental aspects of COVID-19. Front. Immunol. 2024, 15, 1450380. [Google Scholar] [CrossRef]
  155. Calis, J.J.; Rosenberg, B.R. Characterizing immune repertoires by high-throughput sequencing: Strategies and applications. Trends Immunol. 2014, 35, 581–590. [Google Scholar] [CrossRef]
  156. Wang, X.; Fan, D.; Yang, Y.; Gimple, R.C.; Zhou, S. Integrative multi-omics approaches to explore immune cell functions: Challenges and opportunities. iScience 2023, 26, 106359. [Google Scholar] [CrossRef] [PubMed]
  157. Morgan, E.W.; Perdew, G.H.; Patterson, A.D. Multi-omics strategies for investigating the microbiome in toxicology research. Toxicol. Sci. 2022, 187, 189–213. [Google Scholar] [CrossRef] [PubMed]
  158. Roux, S.; Coclet, C. Viromics approaches for the study of viral diversity and ecology in microbiomes. Nat. Rev. Genet. 2026, 27, 32–46. [Google Scholar] [CrossRef]
  159. Aguiar-Pulido, V.; Huang, W.; Suarez-Ulloa, V.; Cickovski, T.; Mathee, K.; Narasimhan, G. Metagenomics, metatranscriptomics, and metabolomics approaches for microbiome analysis. Evol. Bioinform. 2016, 12, 5–16. [Google Scholar] [CrossRef] [PubMed]
  160. Shaffer, J.P.; Nothias, L.F.; Thompson, L.R.; Sanders, J.G.; Salido, R.A.; Couvillion, S.P.; Brejnrod, A.D.; Lejzerowicz, F.; Haiminen, N.; Huang, S.; et al. Standardized multi-omics of Earth’s microbiomes reveals microbial and metabolite diversity. Nat. Microbiol. 2022, 7, 2128–2150. [Google Scholar] [CrossRef]
  161. Pita-Galeana, M.A.; Ruhle, M.; López-Vázquez, L.; de Anda-Jáuregui, G.; Hernández-Lemus, E. Computational metagenomics: State of the art. Int. J. Mol. Sci. 2025, 26, 9206. [Google Scholar] [CrossRef] [PubMed]
  162. Arıkan, M.; Muth, T. Integrated multi-omics analyses of microbial communities: A review of the current state and future directions. Mol. Omics 2023, 19, 607–623. [Google Scholar] [CrossRef] [PubMed]
  163. Elrashedy, A.; Mousa, W.; Nayel, M.; Salama, A.; Zaghawa, A.; Elsify, A.; Hasan, M.E. Advances in bioinformatics and multi-omics integration: Transforming viral infectious disease research in veterinary medicine. Virol. J. 2025, 22, 22. [Google Scholar] [CrossRef] [PubMed]
  164. Wijayawardene, N.N.; Boonyuen, N.; Ranaweera, C.B.; de Zoysa, H.K.S.; Padmathilake, R.E.; Nifla, F.; Dai, D.-Q.; Liu, Y.; Suwannarach, N.; Kumla, J.; et al. OMICS and other advanced technologies in mycological applications. J. Fungi 2023, 9, 688. [Google Scholar] [CrossRef]
  165. Case, N.T.; Berman, J.; Blehert, D.S.; Cramer, R.A.; Cuomo, C.; Currie, C.R.; Ene, I.V.; Fisher, M.C.; Fritz-Laylin, L.K.; Gerstein, A.C.; et al. The future of fungi: Threats and opportunities. G3 2022, 12, jkac224. [Google Scholar] [CrossRef]
  166. Corrêa-Junior, D.; Zamith-Miranda, D.; Frases, S.; Nosanchuk, J.D. From the ground to the clinic: The evolution and adaptation of fungi. J. Fungi 2026, 12, 8. [Google Scholar] [CrossRef]
  167. Tayou, S.; Selmaoui, K.; Zarid, M.; El Alaoui, M.A.; Ouazzani Touhami, A.; El Modafar, C.; Douira, A. Fungal diseases of grapevine in Morocco: Current knowledge, limitations, and future perspectives. Not. Sci. Biol. 2026, 18, 112763. [Google Scholar] [CrossRef]
  168. Alves, V.; Zamith-Miranda, D.; Frases, S.; Nosanchuk, J.D. Fungal metabolomics: A comprehensive approach to understanding pathogenesis in humans and identifying potential therapeutics. J. Fungi 2025, 11, 93. [Google Scholar] [CrossRef]
  169. Ijoma, G.N.; Heri, S.M.; Matambo, T.S.; Tekere, M. Trends and applications of omics technologies to functional characterisation of enzymes and protein metabolites produced by fungi. J. Fungi 2021, 7, 700. [Google Scholar] [CrossRef]
  170. Chetty, A.; Blekhman, R. Multi-omic approaches for host–microbiome data integration. Gut Microbes 2024, 16, 2297860. [Google Scholar] [CrossRef]
  171. Scanu, M.; Toto, F.; Petito, V.; Masi, L.; Fidaleo, M.; Puca, P.; Baldelli, V.; Reddel, S.; Vernocchi, P.; Pani, G.; et al. An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients. Front. Cell. Infect. Microbiol. 2024, 14, 1366192. [Google Scholar] [CrossRef]
  172. Licht, P.; Mailänder, V. Multi-omic data integration suggests putative microbial drivers of aetiopathogenesis in mycosis fungoides. Cancers 2024, 16, 3947. [Google Scholar] [CrossRef]
  173. Ortega-Batista, A.; Jaén-Alvarado, Y.; Moreno-Labrador, D.; Gómez, N.; García, G.; Guerrero, E.N. Single-cell sequencing: Genomic and transcriptomic approaches in cancer cell biology. Int. J. Mol. Sci. 2025, 26, 2074. [Google Scholar] [CrossRef] [PubMed]
  174. Lim, J.; Park, C.; Kim, M.; Kim, H.; Kim, J.; Lee, D.S. Advances in single-cell omics and multiomics for high-resolution molecular profiling. Exp. Mol. Med. 2024, 56, 515–526. [Google Scholar] [CrossRef] [PubMed]
  175. Mincarelli, L.; Lister, A.; Lipscombe, J.; Macaulay, I.C. Advances in proteomics. Proteomics 2018, 18, 1700312. [Google Scholar] [CrossRef]
  176. Zhu, T.; Li, T.; Lü, P.; Li, C. Single-cell omics in plant biology: Mechanistic insights and applications for crop improvement. Adv. Biotechnol. 2025, 3, 20. [Google Scholar] [CrossRef]
  177. Jolasun, Y.; Song, K.; Zheng, Y.; Wang, J.; Fonseca, G.J.; Eidelman, D.H.; Ding, J. SIDISH integrates single-cell and bulk transcriptomics to identify high-risk cells and guide precision therapeutics through in silico perturbation. Nat. Commun. 2025, 16, 11271. [Google Scholar] [CrossRef]
  178. Luo, H.; Hussain, A.; Abbas, M.; Yuan, L.; Shen, Y.; Zhang, Z.; Sun, G.; Yin, X.; Huang, S. Droplet-based single-cell RNA sequencing: Decoding cellular heterogeneity for breakthroughs in cancer, reproduction, and beyond. J. Transl. Med. 2025, 23, 1091. [Google Scholar] [CrossRef]
  179. Chow, A.; Lareau, C.A. Concepts and new developments in droplet-based single-cell multi-omics. Trends Biotechnol. 2024, 42, 1379–1395. [Google Scholar] [CrossRef]
  180. Heimberg, G.; Kuo, T.; DePianto, D.J.; Salem, O.; Heigl, T.; Diamant, N.; Scalia, G.; Biancalani, T.; Turley, S.J.; Rock, J.R.; et al. A cell atlas foundation model for scalable search of similar human cells. Nature 2025, 638, 1085–1094. [Google Scholar] [CrossRef] [PubMed]
  181. Acera-Mateos, M.; Adiconis, X.; Li, J.K.; Marchese, D.; Caratù, G.; Hon, C.C.; Tiwari, P.; Kojima, M.; Vieth, B.; Murphy, M.A.; et al. Systematic evaluation of single-cell multimodal data integration enhances cell type resolution and discovery of clinically relevant states in complex tissues. Genome Biol. 2026, 27, 64. [Google Scholar] [CrossRef]
  182. Wilson, P.C.; Muto, Y.; Wu, H.; Karihaloo, A.; Waikar, S.S.; Humphreys, B.D. Multimodal single-cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression. Nat. Commun. 2022, 13, 5253. [Google Scholar] [CrossRef] [PubMed]
  183. Lee, Y.; Lee, M.; Shin, Y.; Kim, K.; Kim, T. Spatial omics in clinical research: A comprehensive review of technologies and guidelines for applications. Int. J. Mol. Sci. 2025, 26, 3949. [Google Scholar] [CrossRef] [PubMed]
  184. Chen, T.Y.; You, L.; Hardillo, J.A.U.; Chien, M.P. Spatial transcriptomic technologies. Cells 2023, 12, 2042. [Google Scholar] [CrossRef]
  185. Cervilla, S.; Grases, D.; Perez, E.; Real, F.X.; Musulen, E.; Aprea, J.; Esteller, M.; Porta-Pardo, E. A technical comparison of spatial transcriptomics platforms across six cancer types. Genome Biol. 2026, 27, 22. [Google Scholar] [CrossRef] [PubMed]
  186. Cervettini, D.; Tang, S.; Fried, S.D.; Willis, J.C.; Funke, L.F.; Colwell, L.J.; Chin, J.W. Rapid discovery and evolution of orthogonal aminoacyl-tRNA synthetase–tRNA pairs. Nat. Biotechnol. 2020, 38, 989–999. [Google Scholar] [CrossRef]
  187. Emwas, A.H.; Szczepski, K.; Al-Younis, I.; Lachowicz, J.I.; Jaremko, M. Fluxomics—New metabolomics approaches to monitor metabolic pathways. Front. Pharmacol. 2022, 13, 805782. [Google Scholar] [CrossRef]
  188. Lane, A.N.; Higashi, R.M.; Fan, T.W. NMR- and MS-based stable isotope-resolved metabolomics and applications in cancer metabolism. TrAC Trends Anal. Chem. 2019, 120, 115322. [Google Scholar] [CrossRef]
  189. Hilovsky, D.; Hartsell, J.; Young, J.D.; Liu, X. Stable isotope tracing analysis in cancer research: Advancements and challenges in identifying dysregulated cancer metabolism and treatment strategies. Metabolites 2024, 14, 318. [Google Scholar] [CrossRef]
  190. Danzi, F.; Pacchiana, R.; Mafficini, A.; Scupoli, M.T.; Scarpa, A.; Donadelli, M.; Fiore, A. To metabolomics and beyond: A technological portfolio to investigate cancer metabolism. Signal Transduct. Target. Ther. 2023, 8, 137. [Google Scholar] [CrossRef]
  191. Lagziel, S.; Lee, W.D.; Shlomi, T. Studying metabolic flux adaptations in cancer through integrated experimental–computational approaches. BMC Biol. 2019, 17, 51. [Google Scholar] [CrossRef]
  192. Bilder, R.M.; Sabb, F.W.; Cannon, T.D.; London, E.D.; Jentsch, J.D.; Parker, D.S.; Poldrack, R.A.; Evans, C.; Freimer, N.B. Phenomics: The systematic study of phenotypes on a genome-wide scale. Neuroscience 2009, 164, 30–42. [Google Scholar] [CrossRef]
  193. Jangra, S.; Chaudhary, V.; Yadav, R.C.; Yadav, N.R. High-throughput phenotyping: A platform to accelerate crop improvement. Phenomics 2021, 1, 31–53. [Google Scholar] [CrossRef]
  194. Angidi, S.; Madankar, K.; Tehseen, M.M.; Bhatla, A. Advanced high-throughput phenotyping techniques for managing abiotic stress in agricultural crops—A comprehensive review. Crops 2025, 5, 8. [Google Scholar] [CrossRef]
  195. Koch, L. Single-cell transcriptomes in space. Nat. Rev. Genet. 2018, 19, 64–65. [Google Scholar] [CrossRef]
  196. Glancy, B.; Balaban, R.S. Energy metabolism design of the striated muscle cell. Physiol. Rev. 2021, 101, 1561–1607. [Google Scholar] [CrossRef]
  197. Grigorean, V.T.; Dumitru, A.V.; Tataru, C.I.; Serban, M.; Ciurea, A.V.; Munteanu, O.; Radoi, M.P.; Covache-Busuioc, R.A.; Cosac, A.S.; Pariza, G. Thermodynamic biomarkers of neuroinflammation: Nanothermometry, energy-stress dynamics, and predictive entropy in glial–vascular networks. Int. J. Mol. Sci. 2025, 26, 11022. [Google Scholar] [CrossRef]
  198. Kruglov, A.G.; Romshin, A.M.; Nikiforova, A.B.; Plotnikova, A.; Vlasov, I.I. Warm cells, hot mitochondria: Achievements and problems of ultralocal thermometry. Int. J. Mol. Sci. 2023, 24, 16955. [Google Scholar] [CrossRef]
  199. Dharan, R.; Barnoy, A.; Tsaturyan, A.K.; Grossman, A.; Goren, S.; Yosibash, I.; Nachmias, D.; Elia, N.; Sorkin, R.; Kozlov, M.M. Intracellular pressure controls the propagation of tension in crumpled cell membranes. Nat. Commun. 2025, 16, 91. [Google Scholar] [CrossRef]
  200. Ochsner, S.A.; Abraham, D.; Martin, K.; Ding, W.; McOwiti, A.; Kankanamge, W.; Wang, Z.; Andreano, K.; Hamilton, R.A.; Chen, Y.; et al. The signaling pathways project, an integrated ’omics knowledgebase for mammalian cellular signaling pathways. Sci. Data 2019, 6, 252. [Google Scholar] [CrossRef]
  201. Yao, W.; Hu, X.; Wang, X. Crossing epigenetic frontiers: The intersection of novel histone modifications and diseases. Signal Transduct. Target. Ther. 2024, 9, 232. [Google Scholar] [CrossRef]
  202. Sudakow, I.; Reinitz, J.; Vakulenko, S.A.; Grigoriev, D. Evolution of biological cooperation: An algorithmic approach. Sci. Rep. 2024, 14, 1468. [Google Scholar] [CrossRef]
  203. Sanches, P.H.G.; de Melo, N.C.; Porcari, A.M.; de Carvalho, L.M. Integrating molecular perspectives: Strategies for comprehensive multi-omics integrative data analysis and machine learning applications in transcriptomics, proteomics, and metabolomics. Biology 2024, 13, 848. [Google Scholar] [CrossRef]
  204. Wörheide, M.A.; Krumsiek, J.; Kastenmüller, G.; Arnold, M. Multi-omics integration in biomedical research—A metabolomics-centric review. Anal. Chim. Acta 2021, 1141, 144–162. [Google Scholar] [CrossRef]
  205. Liu, X.; Shi, J.; Jiao, Y.; An, J.; Tian, J.; Yang, Y.; Zhuo, L. Integrated multi-omics with machine learning to uncover the intricacies of kidney disease. Brief. Bioinform. 2024, 25, bbae364. [Google Scholar] [CrossRef]
  206. Hemme, C.L.; Atoyan, J.; Cai, A.; Liu, C. Challenges and opportunities in multi-omics data acquisition and analysis: Toward integrative solutions. Biomolecules 2026, 16, 271. [Google Scholar] [CrossRef]
  207. Hussein, A.; Prasad, M.; Braytee, A. Explainable AI methods for multi-omics analysis: A survey. arXiv 2024, arXiv:2410.11910. [Google Scholar] [CrossRef]
  208. Dixon, D.; Sattar, H.; Moros, N.; Kesireddy, S.R.; Ahsan, H.; Lakkimsetti, M.; Fatima, M.; Doshi, D.; Sadhu, K.; Hassan, M.J. Unveiling the influence of AI predictive analytics on patient outcomes: A comprehensive narrative review. Cureus 2024, 16, e59954. [Google Scholar] [CrossRef]
  209. Patharkar, A.; Cai, F.; Al-Hindawi, F.; Wu, T. Predictive modeling of biomedical temporal data in healthcare applications: Review and future directions. Front. Physiol. 2024, 15, 1386760. [Google Scholar] [CrossRef]
  210. Hounye, A.H.; Xiong, L.; Hou, M. Integrated explainable machine learning and multi-omics analysis for survival prediction in cancer with immunotherapy response. Apoptosis 2025, 30, 364–388. [Google Scholar] [CrossRef]
  211. Kumar, R.; Ruhel, R.; van Wijnen, A.J. Unlocking biological complexity: The role of machine learning in integrative multi-omics. Acad. Biol. 2024, 2, 1–3. [Google Scholar] [CrossRef]
  212. Chen, J.; Wang, Y.; Ko, J. Single-cell and spatially resolved omics: Advances and limitations. J. Pharm. Anal. 2023, 13, 833–835. [Google Scholar] [CrossRef]
  213. Alyatimi, A.; Iqbal, M.A.; Chung, V.; Zandavi, S.M.; Anaissi, A. Transforming multi-omics data into images for disease classification: A review of techniques and tools. J. Pathol. Inform. 2026, 20, 100543. [Google Scholar] [CrossRef]
  214. Wu, Y.; Xie, L. AI-driven multi-omics integration for multi-scale predictive modeling of genotype–environment–phenotype relationships. Comput. Struct. Biotechnol. J. 2025, 27, 265–277. [Google Scholar] [CrossRef]
  215. Kim, D.-H.; Kim, Y.-S.; Son, N.-I.; Kang, C.-K.; Kim, A.-R. Recent omics technologies and their emerging applications for personalised medicine. IET Syst. Biol. 2017, 11, 87–98. [Google Scholar] [CrossRef]
  216. Ivanisevic, T.; Sewduth, R.N. Multi-omics integration for the design of novel therapies and the identification of novel biomarkers. Proteomes 2023, 11, 34. [Google Scholar] [CrossRef]
Figure 1. Future Prospects in Omics Sciences.
Figure 1. Future Prospects in Omics Sciences.
Jgbg 01 00008 g001
Figure 2. Functional Layers Beyond Central Dogma.
Figure 2. Functional Layers Beyond Central Dogma.
Jgbg 01 00008 g002
Figure 3. Regulatory Omics Framework.
Figure 3. Regulatory Omics Framework.
Jgbg 01 00008 g003
Figure 4. Organism–Environment Omics Interface.
Figure 4. Organism–Environment Omics Interface.
Jgbg 01 00008 g004
Figure 5. Resolution Scale in Omics.
Figure 5. Resolution Scale in Omics.
Jgbg 01 00008 g005
Figure 6. Multi-Omics Integration Pipeline.
Figure 6. Multi-Omics Integration Pipeline.
Jgbg 01 00008 g006
Table 1. Core Omics Overview.
Table 1. Core Omics Overview.
OmicsTarget MoleculeTechnologyOutputApplications
GenomicsDNANGSVariantsEvolution, breeding
TranscriptomicsRNARNA-seqExpressionRegulation
ProteomicsProteinsMSAbundance/PTMsFunction
MetabolomicsMetabolitesLC-MS/NMRMetabolic profilePhenotype
Table 2. Functional vs. Structural Omics.
Table 2. Functional vs. Structural Omics.
CategoryOmicsMeasured FeatureStatus
FunctionalInteractomicsNetworksEstablished
FunctionalPhosphoproteomicsPTMsAdvanced
StructuralConformomic3D dynamicsEmerging
SpeculativeVibratomicsVibrationsHypothetical
Table 3. Emerging Regulatory Omics.
Table 3. Emerging Regulatory Omics.
OmicsMeasuresTypeMaturityKey Application
AdaptomicsTrajectoriesDynamicEmergingStress biology
ResiliomicsRecoverySystemEmergingRobustness
Chrono-adaptomicsTimeTemporalEmergingCircadian
PlasticomicsMemoryAdaptiveConceptualPriming
Table 4. System-Specific Omics Domains.
Table 4. System-Specific Omics Domains.
FieldBiological SystemKey TechnologiesApplications
Neuro-omicsBrainSpatial omicsNeurodegeneration
ImmunomicsImmune systemRepSeqVaccines
MicrobiomicsMicrobiotaMetagenomicsHealth
MycomicsFungiMulti-omicsBiotechnology
Table 5. Advanced & Speculative Omics.
Table 5. Advanced & Speculative Omics.
OmicsDimensionMeasurable Today?Technology
Single-cellCellularYesscRNA-seq
SpatialTissueYesVisium
FluxomicsDynamicYesIsotope tracing
EnergomicsEnergyNoFuture
ThermomicsHeatNoEmerging
Bioenergetic omicsEnergy integrationNo (Emerging)Future biosensors
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zarid, M. Future Prospects for Omics Sciences: Expanding the Boundaries of Systems Biology. J. Genome Biotechnol. Genet. 2026, 1, 8. https://doi.org/10.3390/jgbg1020008

AMA Style

Zarid M. Future Prospects for Omics Sciences: Expanding the Boundaries of Systems Biology. Journal of Genome Biotechnology and Genetics. 2026; 1(2):8. https://doi.org/10.3390/jgbg1020008

Chicago/Turabian Style

Zarid, Mohamed. 2026. "Future Prospects for Omics Sciences: Expanding the Boundaries of Systems Biology" Journal of Genome Biotechnology and Genetics 1, no. 2: 8. https://doi.org/10.3390/jgbg1020008

APA Style

Zarid, M. (2026). Future Prospects for Omics Sciences: Expanding the Boundaries of Systems Biology. Journal of Genome Biotechnology and Genetics, 1(2), 8. https://doi.org/10.3390/jgbg1020008

Article Metrics

Back to TopTop